Proliferation of Schwann Cells Induced by Axolemmal and Myelin Membranes by Dinneen, Michael Paul
Virginia Commonwealth University
VCU Scholars Compass
Theses and Dissertations Graduate School
1985
Proliferation of Schwann Cells Induced by
Axolemmal and Myelin Membranes
Michael Paul Dinneen
michael.dinneen@ha.osd.mil
Follow this and additional works at: http://scholarscompass.vcu.edu/etd
Part of the Biochemistry Commons
© The Author
This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in
Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact libcompass@vcu.edu.
Downloaded from
http://scholarscompass.vcu.edu/etd/4523
I � 
PROLIFERATION OF SCHW ANN CEllS INDUCED BY 
AXOLEMMAl AND MYELIN NEMBRANES 
A thesis submitted in partial fulfillment of the requirements for the degree 
of Doctor of Philosophy at Virginia Commonwealth University. 
by 
Michael Paul Dinneen 
B.A., Harvard University, 1 978 
M.D., Medical College of Virginia, 1 982 
Director: George H.  DeVries 
Professor 
Department of Biochemistry 
Virginia Commonwealth University 
Richmond, Virginia 
July, 1 98 5  
School of Basic Sciences 
Virginia Commonwealth University 
This is to certify that the thesis prepared by Michael P. Dinneen entitled 
"Proliferation of Schwann Cells Induced by Axolemmal and Myelin 
Membranes" has been approved by his committee as satisfactory 
completion of the thesis requirement for the degree of Doctor of 
Philosophy. 
DIrector of he SIS 
en Chair man or e e' tative 
Table of Contents 
Page 
ACKNOWLEDGEMENTS iv 
LIST OF TABLES v 
LIST OF FIGURES vi 
ABSTRAct viii 
I .  INTRODUctION 
The Schwann Cell ''Life Cycle" 
The Neuron as Promoter of Schwann Cell Proliferation 
During Development -t 
Myelin as Promoter of Schwann Cell Proliferation 
During Wallerian Degeneration 1 1  
I I .  MATERI ALS AND METHODS 1 7  
Tissue EIcision and Cell Dissociation 1 8  
Schwann Cell Tissue Culture 1 9  
Anti-Thy l . l  Complement Mediated Lysis 1 9  
Preparation of Oligodendrocyte Cultures 20 
Oligodendrocyte and Astrocyte Cell Separation Procedure 2 1  
Tritated Thymidine Incorporation Assay 22 
Preparation of AIolemma and Myelin Enriched Fractions 
from Rat CNS 23 
Preparation of Human AIolemma Enriched Fractions 2-t 
Preparation of AIolemma and Myelin Enriched Fractions 
from Peripheral Nervous System 2S 
Preparation of Alternate Membrane Fractions from Rat 26  
I mmunofluorescent Studies 26 
Trypsin Treatment 27 
Enzymatic Assays 28 
Azocasein Assay for Proteolytic Activity 2 8  
Endoglycosidase Treatment 29  
ii 
Solubilization of the Alolemma Enriched Fraction 29 
I solation of Whole Brain Lipids from Rat 30 
Preparation of Lipid Vesicles and Incorporation of 
Solubilized Membrane Fractions into Lipid Vesicles 3 1  
I I I .  RESULTS 32 
Establishment of Schwann Cell Growth Conditions 32 
Immunologic Identification of Schwann Cells and 
Fibroblasts 35  
Measurement of Mitogenic Activity 37 
Mitogenic Response to Cholera TOlin 4 1  
Mitogenic Response to the Alolemma Enriched Fraction 43 
Distribution of Mitogenic Activity Within the Sucrose 
Density Gradient 47 
Comparison of the Mitogenic Activity from Alolemma 
and Myelin Enriched Fractions 5 1  
Schwann Cell Proliferation Induced by Membrane 
Fractions from Other Sources 6 1  
Alolemma Enriched Fractions from Multiple Sclerosis 
Plaque Stimulate Schwann Cell Proliferation 63  
I s  the Schwann Cell Proliferative Response Specific? 63  
Stimulation of OIigodendroglial Proliferation 65  
Solubilization and Eltraction of the Alolemmal Mitogen 66  
IV.  DISCUSSION 7 1  
Preparation of Purified Schwann Cell Cultures 7 1  
Identification of Schwann Cells 75 
Alonal and Myelin Associated Schwann Cell Mitogens 76 
Myelin as a Schwann Cell Mitogen 80 
Alolemma Enriched Fraction from MS Actively 
Stimulates Schwann Cell Proliferation 83 
Summary 84  
V .  REFERENCES 87 
VITAE 
iii 
ACKNOWLEDGEMENTS 
I wish to thank my wife, Patty, for her love, support, and her patience. 
·She shares in every way any success I may attain. 
I wish to thank my parents, Mary and Gerry Dinneen, who instilled in 
me an interest in learning and in scholarly inquiry and who accept me as I 
am. 
I wish to thank Richard Ridenour who has helped me to enjoy the 
struggle. 
Finally, I thank George DeVries who gently guided me in my work and 
patiently prodded me into finishing this project. He has shown me, by 
example, how exciting science can be. 
iv 
Table 
2 
3 
List of Tables 
Title Page 
Fibroblast Contamination as a function of the 34 
Length of Time Following ARA -C Treatment 
Prior to Anti-Thy 1.1 Complement Mediated 
Lysis 
Schwann Cell Mitogenic Stimulation Measured 
by Radioautography 
A. ) Time After ARA-C Treatment VS. MaIimal 
Mitogenic Stimulation 
B.) Time After Anti-Thy 1 . 1  CML VS. MaIimal 
Mitogenic Stimulation 
40 
46 
Effect of Trypsin on the Mitogenic Activity of 57 
Alolemmal and Myelin Enriched Fractions 
v 
List of Figures 
Figure Title Page 
Indirect Immunofluorescence Anti-Thy 1 . 1  3 6  
Staining o f  a Fibroblast 
2 Indirect I mm unofluorescence Anti-CNPase 38 
Staining of Schwann Cells 
3 Indirect Immunofluorescence Micrograph of a 39 
Schwann Cell Culture, Showing Absence of 
Specific Staining 
4 Dose Dependent Mitogenic Response of Cultured 42 
Schwann Cells to Cholera TOlin 
5 Dose Dependent Mitogenic Response of Cultured 44 
Schwann Celts to the Alolemma Mitogens 
6 Morphologic Response of Cultured Schwann Cells 45 
t o  Mitogens 
7 The Distribution of Mitogenic Activity in Membrane 49 
Enriched Fractions Derived From Rat Brain 
8 Dose Dependent Mitogenic Response of Cultured 52 
Schwann Cells t o  Alolemma and Myelin Enriched 
Fractions 
9 Effect of Timed Incubation at Increasing Temper- 54 
ature on the Mitogenic Activity of Alolemmal 
Enriched Fractions 
10 Effect of Prolonged Elposure to Heat on the SS  
Mitogenic Activity of AlOlemmal and Myelin 
Enriched Fractions 
1 1  Reaction Catalyzed by Endoglycosidase D 58 
vi 
Figure Title Page 
12 Appearance of Schwann Cells During Stimulation 60 
by Either Axolemma or Myelin Enriched 
Membrane Fractions 
13 Variation in Schwann Cell Mitogenic Response to 62 
Axolemma Enriched Fractions from Bovine, Rat 
and Human CNS. and Rat PNS 
14 Mitogenic Response of Cultured Schwann Cells to 64 
Axolemmal membranes from Normal Human CNS 
White Matter and Multiple Sclerosis Plaque 
IS Mitogenic Response of Cultured Schwann Cells to 68 
an Axolemma Enriched Fraction Solubilized with 
Octylglucoside 
16 The Proliferative Response of Cultured Schwann 70 
Cells to Axolemma solubilized with Octylglucoside 
and Then Incorporated Into Lipid Vesicles 
vii 
ABSTRACT 
PROLIFERA nON OF SCHW ANN CELLS INDUCED BY 
AXOLEMMAL AND MYELIN MEMBRANCES 
By: Michael Paul Dinneen 
Major Director: Dr. George H. DeVries 
Purified Schwann cells were cultured from neonatal rat sciatic nerve 
using a modification of the method of Brockes (Brockes, J.P. et al, Brain Res. 
165(1979) 105-118). Schwann cells and contaminating fibroblasts were 
unambiguously identified using fluorescent antibodies to 2'3' cyclic 
nucleotide 3 '-phosphodiesterase and the thy 1.1 antigen respectively. The 
Schwann cells were quiescent unless challenged with mitogens, They 
proliferated rapidly in response to the soluable mitogen, cholera tOlin, or to 
membrane fractions from rat CNS or PNS, prepared by the method of 
DeVries (DeVries, G.H., J Neurochem, 40 (1983) 1709-1717). Mitogenic 
activity was present in both axolemmal and myelin enriched fractions and 
promoted a 10-15 fold increase in the rate of 3H-thymidine uptake. The 
alolemmal mitogen was sensitive to heat (800C for 10 minutes), trypsin 
digestion (0.05\ 1 30 mins) or to treatment with endoglycosidase D, 
suggesting that it could be a glycoprotein. Fifty percent of the axolemmal 
mitogenic activity was solubilized in 1\ octyl-glucoside. The solubilized 
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material, however, was very unstable and further purification was not 
possible. 
The myelin associated mitogenic activity was markedly different. It 
was resistant to freeze thaw cycles, trypsin digestion or endoglycosidase 
treatment and the activity was actually enhanced by heating at I oooe for 
two hours. It is proposed that the alolemmal activity is responsible for 
Schwann cell proliferation during development and that the myelin 
associated activity promotes Schwann cell proliferation during Wallerian 
degeneration. 
Introduction 
The myelin producing cells of the peripheral nervous system have 
been studied eItensively since their description by Schwann in 1839. 
(Schwann, 1839) The development of Schwann cells is an ordered 
process,(Webster, 1975) and is accompanied by alterations in both 
morphology and functional capacity. In this introduction I will review the 
'"life cycle" of Schwann cells with specific emphases on the proliferative 
stages. Schwann cells proliferate during embryonic development and also 
during Wallerian degeneration. The current knowledge of Schwann cell 
proliferation will be reviewed as a preface to presentation of our work 
with mitogens derived from nervous system membrane fractions. 
The Schwann Cell "Life Cycle" 
Throughout development, Schwann cells are in intimate contact with 
neurons. Schwann cells are derived from neural crest precursors which 
proliferate and cross the embryonic mesenchymal layer to invade axonal 
groups beginning on or about the 12th embryonic day in the rat. 
(Diner,1965; Asbury ,1967) These immature Schwann cells possess a large 
rounded cell with an oval nucleus and they assume a bipolar spindle shape 
during migration. The cells migrate into developing nerve, dissecting away 
groups of fetal axons by means of long exploratory cytoplasmic processes. 
(Friede and Samorski,1968) They move proximo-distally along 
unmyelinated fibers and undergo a period of rapid proliferation. As 
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constituents of the peripheral nervous system they eventually reside in an 
area bounded prolimally by the glia limitans of the spinal cord and distally 
by certain peripheral tissues such as the epidermis. Initially a number of 
alons are engulfed either singly or communally within invaginations of 
each Schwann cell. (Gamble,1966) As this perinatal proliferation continues, 
more and more alons are segregated into 1:1 relationships with Schwann 
cells. Proliferation slows as Schwann cells begin to produce a basal lamina. 
The basal lamina surrounds each alon-Schwann cell unit and its production 
precedes myelination. The onset of myelination is accompanied by 
Schwann cell hypertrophy and a decline in Schwann cell proliferation on 
about the second post natal day in the rat. The largest alons become fully 
myelinated whereas smaller alons remain ensheathed but unmyelinated. 
The process of myelination has recently been reviewed. (GOUld, 1982; 
Asbury,1975) 
Once myelination is complete, Schwann cell proliferation ceases and 
Schwann cell numbers remain stable unless there is nerve damage. 
Within 2 hours of nerve transection or crush, hydrolytic enzymes are 
increased in Schwann cells distal to the crush. (Hallpike, 1976; Joseph. 
1975) The myelin swells within the first 12-24 H (Webster, 1965) and 
begins to segment into ovoids paranodally. As Schwann cell lysosomal 
activity increases, the myelin is digested in a process termed autophagy. 
(Holtzman and Novikoff, 1965) About 4 days after the injury, Schwann 
cells commence proliferation. (Asbury, 1975; Abercrombie and Johnson, 
1946; Thomas, 1948) They form "bands of Bungner" by lining up with 
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Schwann tubes. The Schwann tubes consist of the original Schwann cell 
basement membrane and adjacent collagen fibers. (Holmes and Young, 
1942; Thomas, 1966) The Schwann cells cease proliferation several weeks 
after the injury and then remain mitotically quiescent until an axon 
re-enters a Schwann tube enroute to its original target tissues. Thus, after 
injury, axons are guided to their destinations by Schwann cells, whereas 
during normal development, Schwann cells follow alons to their 
destinations. (Thomas, 1970) 
From this discussion, it can be seen that there are 2 periods during the 
Schwann cell "life cycle" when proliferation occurs. The first proliferative 
phase happens during development while the second results from nerve 
damage. The signals promoting proliferation have been studied and there 
is indirect evidence that there are distinct mitogenic signals acting during 
these two periods of proliferation. (Salzer, 1980 a) It is clear that there is 
constant communication between the axon and the Schwann cell 
throughout life and I will review the experiments that have clarified the 
nature of that interaction during proliferative periods. Specifically, there is 
evidence that Schwann cell proliferation is neuronally mediated during 
development but that after injury it is induced by the destruction of 
myelin. 
The Neuron as Promoter of Schwann Cell Proliferation 
During Development 
4 
Axonal extension precedes and promotes Schwann cell proliferation in 
the peripheral nervous system. This was observed with the initial 
description of the axonal growth cone by Ramon y Cajal in 1 9 52. (Ramon y 
Cajal, 1 95 2 )  Direct observation through the skin of the developing tadpole 
revealed that the front of sensory nerves invading the body tissues 
consisted of actively advancing neuritic growth cones. (Spiedel, 1 9 64) 
Sheath (i.e., Schwann) cells were added secondarily, and proximal to this 
front of advancing neurons. If the lateral line nerve (a sensory nerve) was 
transected there was a significant reduction in the number of glial cells 
surviving three months after transection. This data suggested that viable 
neurites were necessary for Schwann cell proliferation. 
A study of rat peripheral nerves found that axonal differentiation 
precedes Schwann cell proliferation. Labeling experiments with tritiated 
thymidine established that neuronal division ceased about four days before 
birth. (Lawson, 1 974) Schwann cells rapidly proliferated from this point 
on so that their number increased by twenty-fold in the final three 
embryonic days and as many as 5'l: of Schwann cell nuclei were in mitosis 
at any one time. (Peters and Muir, 1 95 9; Martin, 1 942) Although Peters 
and Muir were unable to discern Schwann cell mitoses after birth in the 
phrenic nerve, a later study using electron microscopy revealed Schwann 
cell mitoses up to nine days after birth. (Diner, 1 96 5 )  Both of these authors 
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noted that Schwann cell mitosis occurred in relation to the aIons in a 
manner which maximized surface contact between the two cells. This 
implied that cell to cell contact between aIon and Schwann cell encouraged 
Schwann cell reproduction. (Martin and Webster, 1 973) 
Two experiments using Nerve Growth Factor demonstrated the 
dependence of Schwann cell proliferation on axonal growth. Subcutaneous 
administration of Nerve Growth Factor to newborn rats caused an increase 
in the number of surviving neurons in the largely unmyelinated 
sympathetic ganglia. Nerve Growth Factor given to newborn rats had no 
effect on the initiation of neuronal division but caused a significant 
increase in the number of dividing non-neuronal cells. (Hendry, 1977) 
Since Nerve Growth Factor does not cause proliferation of isolated cultured 
glial cells (McCarthy and Partlow, 1978; Salzer et aI., 1980 a) the observed 
increase in glial proliferation was ascribed to an indirect effect of increased 
neuronal survival. Conversely, when rats were treated with anti-serum to 
Nerve Growth Factor for five days after birth and then sacrificed four to 
six weeks later, there was a 76" decrease in the number of axons and a 
66\ decrease in the number of Schwann cells in sympathetic nerves. 
(Aguayo, Martin and Bray, 1972) Together these experiments suggest that 
nons exert significant 
development. 
control over Schwann cell growth during 
While evidence from observations of living organisms can give insight 
into the mechanisms of growth, experimental manipulation of cellular 
interactions in intact animals is difficult, as the interacting cells are buried 
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within the organism away from our view. Tissue cu1t.ure methods offer 
both direct visualization of interacting cells and ease of experimental 
manipulation. These methods are ideally suited to the study of 
intercellular communication leading to proliferation. It can be argued, 
however, that tissue culture methods lead to error, because cellular 
behavior in vitro may not mimic the behavior of cells in their native 
environment. This points only to the necessity for caution in the 
interpretation of tissue culture observations, and does not limit the value 
of this method for the study of cellular interaction. 
Tissue culture has long been used in the study of the nervous system. 
In 1 9 1 0, Harrison observed the extension of axons in tissue culture. He 
noted that Schwann cells appeared to follow the developing axons and to 
proliferate in close assoiciation with axons. He suggested that Schwann cells 
follow a cue given by developing axons. (Harrison, 19 10) Many years 
elapsed before methods to obtain purified neuronal cell types were 
developed. Once they were available, however, purified non-neuronal cells 
were exposed to homogenates of sympathetic neurons in culture and a 
dramatic increase in 3H-thymidine uptake by the glial cells was observed. 
(Hanson and PartJow, 1979; McCarthy and PartJow, 1976) It was proposed 
that neurons contained substances which are potent mitogens for 
non-neuronal cells. This study, however, failed to identify unambiguously 
the cells which were stimulated to proliferate. 
Purified cultures of Schwann cells were obtained by Brockes from 
neonatal rat sciatic nerve. (Brockes, I 979) In this preparation, nerves 
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were first digested with trypsin and then the resultant mixture of 
quiescent Schwann cells and dividing fibroblasts was subjected to 
treatment with anti-mitotic agents. The rapidly proliferating fibroblasts 
were virtually eliminated by the anti-mitotic agents with any remaining 
fibroblasts being destroyed via anti-thy 1.1 complement mediated lysis. 
The thy 1.1 antigen was used to identify fibroblasts whereas the RAN- l 
antigen identified Schwann cells (Rafr, 1979; Brockes, I 977; Fields,1978; and 
Fields,1975). The purified Schwann cells obtained by this method 
responded to soluble mitogens which acted via two distinct pathways. 
Cyclic AMP and cholera toxin, which both increased intracellular cyclic 
AMP, caused Schwann cells both to proliferate and undergo morphologic 
change (See figure 5). A soluble factor obtained from extracts of bovine 
pituitary induced Schwann cell proliferation, but did not change cell 
morphology and acted via a mechanism independent of changes in 
intracellular cyclic AMP (Brockes,1980b and 1981b). These investigators 
did not study the effect of membrane bound milogens on purified Schwann 
cells. The physiologic importance of soluble Schwann cell growth factors 
remains unclear but soluble mitogens could be used to produce large 
quantities of purified Schwann cells for further research. 
Wood and Bunge developed a preparation of pure Schwann cells, 
obtained from embryonic dorsal root ganglia, and studied the effects of 
membrane bound mitogens on these cultures (Wood, 1975). Briefly, dorsal 
root ganglia were dissected from 17 day old fetuses and cultured in the 
presence of antimitotic agents which eliminated rapidly proliferating 
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fibroblasts. The resultant cultures contained only sensory neurons, a few 
fibroblasts, and Schwann cells, which were all identifiable morphologically. 
Pure Schwann cells were obtained when the ganglionic mass containing 
the neuronal somata was excised microsurgically. After neurite 
breakdown, the pure Schwann cells became quiescent with less than 5\ of 
Schwann cells incorporating 3H-Thymidine. When bare neurites were 
allowed to grow back into the Schwann cell bed, an area of rapid Schwann 
cell proliferation developed, and more than 90\ of Schwann cells in contact 
with neurites incorporated 3H -Thymidine. Groups of Schwann cells which 
were not invaded by neurites did not proliferate. Thus, not only did 
neurites promote Schwann cell proliferation, but direct contact appeared 
necessary for the mitogenic effect (Wood,1975). 
A more detailed examination of Schwann cell proliferation using this 
culture system was undertaken by Salzer. (Salzer,1980 a,b,c) If sensory 
neurites were allowed to grow into a bed of quiescent Schwann cells, there 
was an initial burst of proliferation by Schwann cells in direct contact with 
neurites as shown earlier by Wood (1975). When this process was allowed 
to continue, Schwann cells ensheathed individual lUons, ceased 
proliferation, and then began myelination of the Jarger neuritic fibers, thus 
recapitulating the stages of normal development and giving credence to the 
theory that direct lUonal contact is the mitogenic stimulus for Schwann cell 
proliferation in normal development. 
A membrane fraction prepared from sensory ganglion neurites was 
also mitogenic for isolated Schwann cells. This membrane fraction 
increased the labeling index of Schwann cells from less than 0.2\ to more 
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than 10,; as assessed by autoradiography. (Salzer,1980 b) Membrane 
preparations from fibroblasts or 3T3 cells did not stimulate proliferation, 
nor did the soluable fraction from the sensory ganglion preparation. This 
demonstrated that the neurite mitogen was both membrane bound and 
specific. 
The neurite mitogen was inactivated by heat (80'C x 10 mins.), mild 
trypsin treatment (0.05'; x I H )  or aldehyde fixation. On this basis it was 
proposed that the mitogen is a membrane bound protein. The absolute 
necessity for cell cell contact was established by growing Schwann cells and 
neurites on opposite sides of a 6mm thick permeable collagen diaphragm. 
Under these conditions no Schwann cell proliferation was observed. 
(Salzer, 1 980c) Although Salzer's elegant work contributed much to the 
understanding of the axonal Schwann cell mitogen, the dorsal root ganglion 
culture system was extremely difficult to reproduce and the neurite 
mitogen was available in only minute quantities. (200 to 300 dorsal root 
ganglia yielded only approximately 400 Jig of membrane protein.) 
In an effort to find a more plentiful source of the alonal mitogen, 
DeVries et al. (1982) challenged quiescent dorsal root ganglion derived 
Schwann cells with an axolemmal enriched fraction from rat central 
nervous system white matter. The Schwann cells responded with an 
increase in labeling index from 0.28'; to 12.18'; measured by 
autoradiography. This was surprising since axolemmal fractions were 
prepared from fully differentiated myelinated nerves in which Schwann 
cells would normally be quiescent. The authors speculated that "intact 
mature but unensheathed" alons may be mitogenic (DeVries, 1982). 
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Schwann cells also responded to alolemmal enriched fractions 
prepared from rat peripheral nervous system; bovine central nervous 
system and bovine pheripheral nervous system sources. The aIolemmal 
mitogen was sensitive to trypsin and heat (80'C I 10 mins) but withstood 
either a 25 hour, 34'C incubation or a freeze thaw cycle, both of which 
inactivated the neurite mitogen (DeVries, 1982; Salzer, 1980c). It was 
proposed that the alolemmal mitogen was either chemically different or 
packaged in a more protected environment as a result of myelination. 
Schwann cells prepared from neonatal rat sciatic nerve by the method 
of Brockes (I 979), proliferated in response to rat central nervous system 
alolemma enriched fractions, or cholera tOlin (DeVries, 1983). The 
alolemma mitogen caused a three fold increase in the number of cells in 
the S-phase of the cell cycle during which active DNA replication takes 
place. This data suggested that increased thymidine uptake in response to 
the alolemmal mitogen was due to DNA synthesis and not DNA repair. This 
work also demonstrated that Schwann cells could respond to either 
soluable mitogens such as cholera tOlin or the membrane bound alolemmal 
mitogen. Moreover, these two classes of mitogens appeared to act via 
different mechanisms, since cholera tOlin induced a dramatic morphologic 
transformation which was not observed in alolemma stimulated Schwann 
cells. (DeVries, 1983) 
In a series of elperiments using Schwann cells isolated by differential 
adhesion, Pleasure et al. have confirmed that axolemma enriched fractions 
are mitogenic for Schwann cells. (Kreider, 1982; Sobue, 1983; Kreider, 1981) 
Cells isolated in this manner were only 9Y� pure Schwann cells but had not 
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been elposed to antimitotic agents. They responded with a mali mal 12 
fold increase in 3H Thymidine uptake which is comparable to that found by 
either De Vries (1983)  or Cassel ( 1 98 2 )  using cells previously exposed to 
anti-mitotic agents. This suggested that at least the proliferative response 
of cultured Schwann cells is not hindered by prior exposure of the cell to 
cytosine arabinoside. 
In conclusion, a large body of in vivo and in vitro evidence now exists 
which supports the existence of a neuronal mitogen for Schwann cells. This 
mitogen is membrane bound and located on the exterior surface of growing 
alons. It is sensitive to mechanical, thermal and proteolytic disruption and 
is therefore either a protein or dependent on an environment consisting of 
native proteins for its elpression. It is clear that this mitogen acts during 
normal development but it is not clear whether the alolemmal mitogen is 
responsible for Schwann cell proliferation during Wallerian degeneration. 
Myelin as Promoter of Schwann Cell 
Proliferation During Wallerian Degeneration 
In early quantitative studies of Schwann cell proliferation during 
Wallerian degeneration in sciatic nerve of the rabbit, Abercrombie and 
Johnson ( 1 946)  showed that the Schwann cell population in the distal 
portion of a degenerating nerve increased approximately eight-fold over 
25 days after nerve transection. Cellular proliferation was first observed 
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four days after nerve severance. Interestingly, the authors noted that 
maximal stimulation was associated with the largest "schwann tubes" 
which were remnants of large myelinated fibers. The authors suggested 
that a "diffusable activator" produced by autolysis of nerve fibers caused 
this increase in Schwann cell number in response to 
denervation.(Abercrombie and Johnson, 1946; Holmes and Young, 1942) 
Several investigators noted increased phagocytic activity in Schwann 
cells during Wallerian degeneration (Holmes 1942). The increase in 
Schwann cell lysosomal activity was correlated with segmentation of 
myelin and formation of degenerating ovoids (Holtzman and Novikoff, 
1965). When non-myelinated and finely myelinated rabbit nerves were 
studied during degeneration, not only was there less phagocytic Schwann 
cell activity but there was also less Schwann cell proliferation (Joseph J 
1950). 
It was noted that the least myelinated nerves had the smallest 
increase in Schwann cell nuclei and that the increase in nuclei was roughly 
proportional to the size of the fiber. From this data, they inferred that the 
space left by degenerating nerve fibers dictated the amount of glial 
proliferation, since the final glial cell density was surprisingly similar for 
unmyelinated and lightly myelinated fibers twenty-five days after 
denervation (Thomas,1970 and Joseph,1950). The authors did not suggest 
at that time that products of myelin decomposition could be causing 
Schwann cell proliferation. 
In a more detailed examination of Wallerian degeneration in 
transected rat sciatic nerve, Friede and Johnson (1967) confirmed that, 
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although alons degenerated after two to three days, Schwann cell 
proliferation did not start for at least four days. In addition, the authors 
noted different behaviors in each of three separate anatomical sites. In the 
proximal stump, Schwann cell proliferation began rapidly and was greatest 
near nascent alons. In the distal stump, Schwann cell proliferation began 
within two days of injury and then subsided. However, the distal nerve 
did not show signs of Schwann cell proliferation until day four when 
Schwann cells showed advanced signs of phagocytic activity and myelin 
was actively being degraded. The authors concluded that the "behavior of 
the Schwann cells in Wallerian degeneration is not determined by the 
destruction of axoplasm, but rather by that of myelin _ _ _  These data 
indicate individual and characteristic patterns of cell proliferation for each 
of the affected regions, suggesting the existence of multiple control 
mechanisms of cell proliferation." (Friede and JOhnstone 1 967) 
Similarly, when Wallerian degeneration in unmyelinated cervical 
sympathetic trunks was studied, there was no appreciable Schwann cell 
proliferation in the distal nerve, consistent with the idea that myelin 
degeneration, not alonal degeneration gives rise to Schwann cell 
proliferation (Romine and Aquayo 1 976) .  When mitomycin C, a cross 
linking alkylating agent was injected in10 a site of sciatic nerve injury, both 
Schwann cell autophagy of myelin and Schwann cell proliferation were 
inhibited. The authors speculated that Schwann cell division was a 
prerequisite to autophagy and that Schwann cells had to multiply and 
dedifferentiate before they could begin digesting myelin. (Hall and Gregson, 
1 977 and 1 978) They did not suggest that the reverse sequence might also 
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elplain the elperimental findings. 
Though a cause-effect relationship has not been established, it seems 
clear that Schwann cell proliferation during Wallerian degeneration is 
closely related to the process of myelin degeneration. Some credence was 
given to this argument with the observation that Schwann cell proliferation 
is persistently high in the trembler mouse wherein myelin is constantly 
being broken down secondary to genetic instability (Aquayo 1 979).  
Several theories about the stimulus for Schwann cell proliferation 
have been proposed. The mitogenic signal was first proposed to be axonal 
degenerating debris. That seems unlikely in view of the relative absence of 
Schwann cell mitosis in degenerating unmyelinated nerve. It was then 
proposed that Schwann cell proliferation resulted spontaneously from a 
need to fill space vacated by degenerating nerve fibers. Alternately, 
Schwann cell proliferation was seen as a prerequisite for dedifferentation 
of Schwann cells so they could engage in phagocytic activity and then 
re myelinate new alon sprouts (Aquayo, Charron, Bray 1 976 ). Finally, the 
process of autophagy itself was seen as a stimulus for Schwann cell 
reproduction and dedifferentiation. These various mechanisms remained 
unresolved prior to the advent of tissue culture methods for the study of 
Waller ian degeneration. 
Observations in neuronal tissue culture systems have partially 
clarified the above hypotheses. Salzer observed Wallerian degeneration in 
DRG cultures after neuronal cell bodies were elcised from myelinated cell 
cultures. (Salzer 1 9 80a). He found that those Schwann cells associated 
with myelinated nons were induced to divide, but that Schwann cells 
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associated with degenerating unmyelinated axons remained quiescent. 
This data supported the hypothesis that Schwann cell proliferaion is 
induced by degradation of myelin. 
Since there was ample room in the tissue culture dish for proliferation 
of all Schwann cells, it seemed unlikely that the stimulus for proliferation 
was the vacancy left by degenerating nerve fibers. Also, degeneration of 
myelin competent axons alone did not result in Schwann cell proliferation. 
A continuous axon myelinated in one region of the culture dish did not 
cause Schwann cell proliferation in a portion of the dish where it was 
unmyelinated, suggesting that axonal degenerating debris did not cause 
Schwann cell proliferation. 
De Vries found that a myelin enriched fraction from rat CNS but not 
PNS stimulated isolated Schwann cells with approximately 3 5 \  of the 
efficiency of an axolemmal enriched fraction (DeVries, Bunge 1 98 2 ). At 
that time, it was not possible to discern whether the myelin associated 
mitogenic activity came from 8.l0lemmal contamination of the myelin 
enriched fraction or from intrinsic myelin associated mitogenic activity. 
When myelin prepared by the method of Norton and Poduslo was assessed 
for mitogenic activity, only 1 8 \ of the maximal axolemmal activity was 
recovered (Cassel 1 982 ,  Norton, I 973 ). 
In conclusion, both in vivo and in vitro studies of Schwann cell 
proliferation during Wallerian degeneration are consistent with the theory 
that products of myelin degeneration induce Schwann cell mitosis. Direct 
evidence for the mitogenic activity of myelin associated membranes is not 
available, however. We propose to further characterize the axolem m aJ 
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mitogen and compare it with the myelin associated mitogen. We will 
atte mpt to show that myelin does indeed possess mitogenic activity and 
that the myelin associated mitogen is characteristically different from the 
aIolemmai mitogen. 
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Materials and Methods 
Materials 
Pregnant Sprague Dawley rats were purchased from Dominion Labs, 
Dublin, VA. Components for tissue culture media included Dulbecco's 
modified Eagle's medium (DMEM) and DMEM without bicarbonate b uffered 
with 0.02 M HEPES at pH 7.2 (HE) which were obtained from Gibco. Fetal 
calf serum was purchased from sterile systems, Logan, Utah. CYtosine 
arabiniside and trypsin were purchased from sigma and collagenase from 
Worthington chemicals, Freehold, New Jersey. Tissue culture plastics were 
products of Flow Laboratories, Falcon Plastics, or Corning Industries. 
Rabbit complement was obtained from Cappel and mouse anti Thy- l . 1  
monoclonal antibody was purchased from New England Nuclear. Reagents 
used in im munofluorescent cell labelling studies consisted of rabbit anti-rat 
CNPase ( a generous gift from Dr. Terry Sprinkle), FITC-conjugated goat anti 
rabbit IgG, and FITC-conjugated sheep anti mouse IgG from Cappel 
Laboratories. N-propyl gallate was obtained from Sigma Chemicals. 
The cell harvester and fiber filter disks were purchased from flow 
labs. Endoglycosidase D was obtained from Miles Labs. The enzymatic 
substrates used in this study were of reagent grade and were obtained 
from Sigma Chemicals. 1 ,S-bis94(allyldimethyl-am monium)-phenyl 
penta-3-one dibromide was obtained from Burroughs Wellcome, Research 
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Triangle, NC. 
TiSsue Excision and Cell Dissociation 
The method is a modification of that used by Brockes ( Brockes,JP. 
1 979 ). Two to three day old rat pups are etheriZed, killed by decapitation, 
and pinned out in a laminar flow hood with their hind quarters e:xposed. 
They are rinsed with 85\ ethanol and, using a dissecting microscope, the 
sciatic nerves are e:xposed and removed to five mls of Dulbecco's modified 
Eagle's medium without bicarbonate buffered to pH 7.2 with 0.02 M HEPES 
(HE) in a sterile 10 ml beaker at room temperature. No more than twenty 
five animals are sacrificed at any one time. 
The sterile nerves are transferred to a 50 ml ehrlenmeyer flask with a 
foil cover containing 0.3\ collagenase in 3 mls of HE. After a 15 minute 
incubation at 3TC in a shaking water bath the nerves are allowed to settle 
and the supernatant is decanted and discarded. The procedure is repeated 
two times, first using 0.25\ trypsin in 3 mls of HE and then using a 
combination of 0.25\ trypsin and 0.3\ collagenase. Following the third 
incubation, the supernatant is removed and replaced with 3 mls of 
Dulbecco's modified Eagle's medium containing 10\ fetal calf serum(HF). 
The nerves are triturated 4 times using a sterile pasteur pipet and the 
supernatant is filtered through #209 Nite:x mesh. This procedure is then 
repeated with 2 mls of HF, and then with I ml of HF. 
The filtered suspension is centrifuged for 5 minutes at 1500 rpm at 
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room te mperature. The supernatant is removed and cells are resuspended 
in HF. Five rat pups yield approlimately 2-3' 1 06 cells. The cells are plated 
onto glass 1 0  cm petrie dishes at app. 2 .5" 1 06 cells per dish. Seventy to 
eighty percent of the cells elclude trypan blue dye. 
Schwann Cell Tissue Culture Procedures 
Primary Schwann cell cultures are arown elclusively on alass 1 0  cm 
petrie dishes in HF in a humidified atmosphere of 1 01 carbon diolide at 
37·C. Twenty four hours after platina ,  1 00111 of .00 1 M cytosine arabinoside 
( ARA-C) is added. On day 4, the medium is removed, the cells are rinsed to 
remove ARA-C, and fresh medium is added. The cells are allowed to 
recover from the antimetabolite treatment for at least three days, before 
being rinsed once with phosphate b uffered saline containing 5.4 mM �Cl 
and 41 deltrose (Saline I ), and then re moved from the petrie dish by 
treatment with 4 mls of 0 .011 Trypsin/0.041 EDT A in Saline I for ten 
minutes at 37"C. The reaction is terminated by adding S mls of HF. The 
suspended cells are transferred to centrifuge tubes and then centrifuged at 
800g for S minutes in preparation for the anti-Thy 1 . 1  complement 
mediated lysi s procedure. 
Anti-Thy 1.1 Complement Mediated Lysis 
After centrifugation of the suspended cells, the supernatant is 
re moved and the cells are resuspensed in O.4 mls of HF. NeIt, 1 00jll of fresh 
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undiluted rabbit comple ment and 1 00 �I of a 1 to 20 dilution of anti Thy 
1 . 1  monoclonal antibody are added. The rabbit complement must be 
absolutely fresh for the procedure to be successful, and therefore should be 
reconstituted from lyophilized powder on the day it is used. The centrifuge 
tubes are then vortexed gently and incubated for 30 minutes at 37·C. 
Finally ,the cells are centrifuged for 5 minutes at 500g, the supernatant is 
removed, and the pellet is resuspended in one ml of HF. Cells are counted 
on a hemocytometer and then plated in either Linbro microwel1s at 1 0,000 
cel1s per wel1, or in multiwells at 10, 000 cel1s per wel1.(21 well dish) 
60-70\ of the anti-thy 1 . 1  treated cells excluded trypan blue. This 
procedure produced viable cells which are virtually pure Schwann cells. 
Preparation of Oligodendrocyte Cultures 
The preparation of mixed glial cell cultures from rat cerebral cortex 
has been previously described ( McCarthy and DeVellis 1 980) .  Briefly, one 
to two day old neonatal rats are rinsed in ethanol and then decapitated. 
The cortices are removed and meninges are gently teased off. Cortices are 
transferred to a flask containing 1 0  mls of Saline 1 .  The flask is gently 
agitated in a rotary shaker at 3TC for IS minutes. One ml of I \ trypsin in 
Saline! is added and the flask is returned to the shaker for 30 minutes. 
The flask is removed from the sha1cer and ten mls of Dulbecco's Modified 
Eagle's medium containing 2 mM Glutamine, 0 .5\ glucose(w/v), 
PCN/Streptomycin, and 1 0 \  fetal calf serum are added. Cortices are mixed 
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by trituration with a 1 0  ml pipette. The supernatant containing dissociated 
cells is then filtered through # 1 30 NiLeI. !O mls of BME is again added, 
cortices are triturated, and the supernatant is filtered. This process is 
repeated four times. 
The combined supernatants are centrifuged at 1 00 I g for 5 mins and 
then resuspended in BME. Cells from approlimately 6 rat pups are plated 
in one 75 cm 2 plastic flask in 1 0  mls BME. The initial cultures contain 
considerable floating debris and cell attachment is not complete until day 
three. The medium is changed after 3 days and then three times a week 
thereafter. The use of 1 -2 day old rat pups ensures the absense of viable 
neurons in the cell suspension obtained from cerebral cortel, so that the 
resulting culture contains only astrocytes, oligodendrocytes, and some 
neural fibroblasts. (McCarthy, 1 98 0 )  
Oligodendrocyte and Astrocyte Cell Separation Procedure 
After 7-9 DIV, the astrocytes and oligodendrocytes become stratified 
in the culture dish with the astrocytes forming a bed on which the 
oligodendrocytes lie. The media is changed, and three hours later the tissue 
culture flasks are taped to a rotory shaker (McCarthy, 1 980 )  and are 
shaken for 1 6 - 1 8  H at a setting of 6.5 at 37"C. The media (containing 
suspended oligodendrocytes) is filtered through Nitel# 1 7  and flasks are 
rinsed once with BME. The filtered media is transferred to centrifuge 
tubes and centrifuged at 1 50 I g for 1 5  mins. The pellets are 
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suspended in a small amount of BME and cells are counted with a 
hemocytometer. Sixty to seventy percent of the cells exclude trypan b lue 
dye. Cells are plated in Linbro microwell dishes with 2 x 1 04 cells in I 00 fll 
BME in each well. Cells are allowed to recover for 3-5 days before 
mitogenic stimulation assays. 
Tritiated Thymidine Incorporation Assay 
This assay of schwann cell proliferation is used with cells which had 
been plated onto Linbro microwell dishes. After a 24  hour incubation, a 
mitogen or HF is added to bring the total volume in each well to 
I OOfll.Next, OJ flCi of tritiated thymidine in 2 5flJ of HF is added and the 
cells are incubated for an additional 2 4-72 hours. The cells are then treated 
with trypsin(O.O I !.) and EDT A(0.04!.) for ten minutes at room temperature, 
before being collected on filter paper using a Titertek cell harvester. After 
collection , the cells are rinsed with 0 .9" NaG for 30 seconds, to eliminate 
extraneous thymidine. The filter paper disks are dried and then placed in 
scintillation vials with 5 mls of Beckman Ready Solve scintillation fluid. The 
radioactivity is determined in an Intertechnique SL 3-Scintillation counter. 
All assays are performed in at least triplicate microwells. 
Autoradiography of Schwann Cells 
This assay of Schwann cell proliferation is used with anti-Thy 1 . 1  
treated cells plated onto glass coverslips in 2 4  well plastic culture dishes at 
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a density of <{O,OOO cells per well. The Schwann cells are incubated for 24 
hours and then a mitogen or HF is added to give a final volume of 5 0 0 �1 
per well. Next, 1 .5 mCi of tritiated thymidine in 1 2 5  �l of HF is added to 
each well. After 48 hours the cells are washed and processed for 
autoradiography as previously described (DeVries, 1 983b ). A cell is 
considered positive if there are 2 1 5  grains over the nucleus. At least 500 
cells are counted on each coverslip. 
Preparation of Axolemma and Myelin enriched Fractions 
From Rat CNS 
Alolemma and myelin-enriched fractions were prepared from I gm of 
rat brainstem as previously described (DeVries, 1 983a). Briefly, I gram of 
tissue from rat brain was gently homogenized in buffered salt-sucrose 
media, and centrifuged at 25,000 I g for 30 minutes to obtain a floating 
layer. This floating layer was hypotonically shocked in 1 0 mM TES, and 
homogenized using first a dounce homogenizer and then a Tek mar 
tissuemizer for 30 seconds. The homogenate, which consisted of shocked 
myelinated axons, was separated on a 34 ml linear sucrose gradient 
( 1 0-40\ sucrose, w/w) by centrifugation at 8 5,000 I g for 1 5 - 1 8  hours. 
The gradient was fractionated and the sucrose concentrations were 
determined with a refractometer. Those fractions which were between 28 
and 32\ sucrose (w/w) were pooled for the axolemma and myelin enriched 
fractions, respectively. All preceeding steps were performed in the 
presence of 0 .02\ sodium azide (w/v). The samples were collected by 
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centrifugation and resuspended in sterile Saline I to give a concentration of 
membrane protein between 1 and 3 mg/ml. Protein was determined using 
the microassay of Bradford (Bradford, 1 976)  in the presence of 0 . 1  N NaOH 
with a gamma glob ulin standard. 
Preparation of Human Axolemma Enriched Fractions 
The preparation of lUolemmal fractions from normal human brain and 
m ultiple sclerosis plaque is a modification of the method used for 
fractionation of rat CNS myelinated lUons. Briefly, one gram of post mortem 
normal human white m atter from corpus callosu m  is minced and then 
homogenized in 35 mls of 1 M  sucrose, 1 0  mM TES,and 1 50 mM NaCl using 
a loose dounce homogenizer. The homogenate is then centrifuged at 25,000 
I g for 30  mins. The resultant floating pad of myelinated lUons is 
transferred to 2 mls of 1 0  m M  TES and is homogenized with a Tekmar 
tissuemizer for a total of 30 seconds. The shocked myelinated alons are 
layered over a 34 ml linear sucrose gradient( 1 0-45l  Sucrose w/w), and is 
centrifuged at 78,000 I g for 1 8  hours. All preceeding solutions contain 
0.02l sodium azide. 
The gradient is fractionated and sucrose concentrations are 
determined with a refractometer. A fraction containing 27 -32l sucrose is 
harvested and pelleted at 1 00,000 I g for 2 hours in 1 0  mMTES in a sterile 
test tube. The lUolem m a  enriched fraction is then resuspended in Saline I 
and protein concentration is determined. 
The lUolemma enriched fraction from MS plaque is prepared in a 
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similar manner to the normal human brain preparation elcept that initially 
the whole homogenate is centrifuged at 600 I g for 1 0  mins instead of 
2 5,000 I g for 30 minutes. Since the MS plaque contains only scant myelin, 
it was found that an initial 25,00 I g centrifugation resulted in loss of most 
all of the membranous material. Therefore, the supernatant from the 600 I 
g spin was layered over the linear sucrose gradient and was not subjected 
to additional polytron homogenization. The 27-32 \  fraction of the gradient 
was harvested in the usual manner, and was designated as the alolem mal 
fraction. 
Preparation of Axolemma and Myelin Enriched Fractions 
From Peripheral Nervous System 
PNS oolemma and myelin enriched fractions are prepared as 
previously described (Yoshino, 1 98 3 ). Sciatic nerves are dissected from rats 
that have been sacrificed by decapitation and are stored at -70'C. All 
preparitive steps are carried out at -4 'c. A typical fractionation utilizes 1 .5 g 
of sciatic nerve. The nerves are homogenized with a Tekmar Tissuemizer 
for 30 s in 30 ml of 1 0 \  sucrose (w/w) in 1 0  mM TES, pH7.4, until only 
occasional clumps of connective tissue remain. The homogenate is 
centrifuged at 1 000 I g for 1 0  minutes. The resulting supernatant is 
centrifuged at 85,000 I g for I hour. The high speed pellet is resuspended 
in 3 ml of 1 0  mM TES, rehomogenized with the Tissuemizer for 1 5 -20 
seconds, and layered over a 34-ml continuous sucrose gradient ( 1 0-40\ 
(w/w) in 1 0 m M  TES) that is centrifuged 1 5 - 1 8h at  85 ,000 I g. The bottom 
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of the centrifuge tube is punctured and 25ml  fractions are collected. 
Sucrose concentration is determined using a refractometer and fractions 
from 27-33\ and 1 8-23\ sucrose are collected as axolem mal and myelin 
fractions respectively. 
Preparation of Alternate Membrane Fractions from Rat 
Rats are sacrificed by decapitation and the organs to be studied are 
quickly removed. Membrane fractions are prepared from kidney, liver, 
spleen, and lung. Tissue is minced with a Stadie blade and then 
homogenized in 1 0  volumes of distilled water ( ddH20) usind a dounce 
homogenizer. The crude homogenate is centrifuged at 600 I g for 1 5  
minutes. The pellet is resuspended in 3 volumes of ddH20 and is again 
centrifuged at 600 I g for 1 5  minutes. The pellet is discarded and the 
supernatants are first combined, and then centrifuged at 1 00,000 I g for 
one hour at O ·c. The final membrane pellet is resuspended in Saline r prior 
to protein determination and assay for mitogenic activity. 
Immunofluorescent Studies 
At least twenty-four hours after the removal of cytosine arabinoside 
from the media, Schwann cells which had been plated on CQverslips are 
rinsed with HE and then with phosphate b uffered saline (PBS).For studies 
with anti-CNPase, the cells are filed with 1 \  paraformaldehyde in PBS for 
5 minutes, and then with absolute ethanol for another 5 min. 
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I m munofluorescent labeling of Schwann cells is not observed in the 
absence of fiulion prior to incubation with anti-CNPase. After cells are 
rehydrated with PBS, the coverslips are incubated with 2 '-'  normal goat 
seru m(GIBCO) for ten minutes. Following a ten minute wash with PBS, 
antibody to CNPase is diluted I :50 or I: 1 00 with PBS and added to the cells 
for thirty minutes. The cells are washed in PBS for thirty mins. The 
fluorescein-coupled second antibody, goat anti-rabbit IgG (Cappel 
Laboratories), is diluted 1 : 1 00 or 1 :400 in PBS and centrifuged in a Beck man 
Microfuge for 5 min. The supernatant is added to the cells for 20 min. In 
order to reduce the background fluorescence, the cells are then washed in 
PBS for 3-4 hours. 
The coverslips are mounted on slides in glycerol-PBS (9: 1 )  with 5 '-'  
n-propyl gallate (Sigma Chemicals) which enhances the fluorescence. The 
stained cells are eumined with a Zeiss Ultraphot microscope equipped with 
fluorescent optics. All photomicrographs are exposed for the same length of 
time, approximately 2 minutes. 
For staining with anti-Thy 1 . 1 ,  the cells are rinsed with PBS and 
incubated for 20 min with monoclonal anti-Thy 1 . 1 (New England Nuclear) 
which has been diluted I :50 with PBS. After a 20-minute wash with PBS, the 
fluorescein-coupled second antibody, sheep anti-mouse igM(Cappel 
Laboratories)  is diluted 1 :30 in PBS, centrifuged for 5 min, and added to the 
ceUs for 20 min. The cells are fixed and mounted as described previously. 
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Trypsin Treatment 
For treatment with trypsin, a membrane preparation (0.5 mg protein) 
in ml of Saline I is incubated at 37·C for one hour in the presence of 
trypsin 0.2 mg/ml, soybean trypsin inhibitor (ST I )  0.8 mg/ml, or trypsin and 
STI together. Incubation with trypsin was terminated by the addition of STI 
to give a final concentration of 0 .8 mg/ml. 
Enzymatic Assays 
The assay for 2 '3 '-cyclic nucleotide 3 ' -phosphodiesterase is performed 
as described by Sogin (Sogin 1 976) .  The assay for acetylcholinesterase is 
performed as described by Hall (Hall Z.W., 1 973) .  The samples are assayed 
for both activities immediately after isolation. All enzymatic analyses are 
determined as initial velocities and are run in duplicate at two different 
protein concentrations. the reaction velocities are linear with respect to 
protein concentration over the range used. 
Azocasein Assay for Proteolytic Activity 
Samples to be assayed for proteolytic activity are diluted in 600f.l1 of 
20mM ethanolamine and 0. 1 4  M NaC! at pH 9.5 and are warmed to 37"C in a 
water bath. To commence the reaction, 0 . 5  mls of azocasein (22  mg/ml) in 
20mM ethanolamine and 0 . 1 4  M NaC! at pH 9.5 is added to the diluted 
sample and the solution is vortexed im mediately. At 1 5 ', 30 ', 4 5 ', and 60 ', 0 .5 
ml aliquoLS are removed and added to I ml of 5 "  trichloro acetic acid (w/v). 
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Each TCA precipitated sample is then centrifuged for 2 mins in a Beck man 
microfuge at room temperature and absorbance at 340 nm is recorded. 
Trypsin is used as a positive control to standardize the assay. 
EndogIycosidase Treatment 
Endoglycosidase D (Miles Laboratories) is reconstituted from 
lyophilized powder and then stored at -20"c' O.S mg aliquots of alolem ma 
or myelin enriched fractions in HE at pH 7.0 are thawed and then incubated 
with from 2 to 40 mU of Endoglysidase D at 37"C for 1 2H. Control samples 
are incubated with equal volu mes of 0 . 1  \ BSA in ddH20 at 37"C for 1 2  
hours. Since 2 0  mU of endoglycosidase D will completely hydrolyze 1 � mole 
of susceptible glycopeptide in one hour at saturated substrate concentrations 
(Koide,N., 1 974) ,  then these conditions should result in complete degradation 
of susceptible glycoproteins in a membrane fraction containing less than one 
mg of protein. After endoglycosidase treatment, the axolemma or myelin 
enriched fractions are assessed for mitogeniC activity as previously 
described. 
Solubilization of the Axolemma Enriched Fraction 
One mg of lUolem mal membrane fraction in Saline 1 is miled with 
ml of 2 \  B-D-octylglucopyranoside (OG) (or deorycholate or cholate) in 
0 .02\ azide, 1 0m M  TES, SO mM NaCl, I mM EDTA, and 1 0 \  sucrose ( dialysis 
b uffer). The solution is incubated with gentle agitation for 30 minutes at 
room temperature. The solubilized material is centrifuged at 1 00 ,000 I g for 
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one hour and supernatant is decanted. A scan from 400-240 nm is obtained 
to quantitate protein concentration and to rule out light scattering from 
undissolved particles. The solution is then put into a dialysis b ag and is 
dialyzed against dialysis b uffer for 24 hours in the cold (0-4'C) with gentle 
continuous stirring. We adjusted the concentration of detergent in the 
dialysate to maintain a minimum concentration of OG to prevent 
precipitation of solubilized material. The dialyzed material is again scanned 
to enwre that no precipitation had occured. Then, the dialyzed solubilized 
membrane fractions are added to cells within 6 hours of completion of 
dialysis. Controls, consisting of detergent alone are run concurrently with 
membrane fractions. 
Isolation of Whole Brain Upids From Rat 
The extraction of whole brain lipids is accompl;ished according to the 
method of Bligh and Dyer (Bligh and Dyer , 1 9 5 9 ). Adult female Sprague 
Dawley rats, 250-300 grams, are sacrificed by asphiliation and then whole 
brain is removed and minced with a Stadie blade. The brain is homogenizeed 
with a dounce homogenizer an distilled water and then pulverized with a 
Tek mar tissuemizer for 30 seconds. 1 7  volumes of CHCI3 :MeOH,2: l (v/v) are 
added and suspension is sonicated to aid lipid solubilization. 8 volu mes of 
MeOH are added and the suspension is centrifuged at 900 rpm at room 
temperature for 20 minutes. The supernatant is removed to a separatory 
funnel and 1 7  volumes of CHCl3 are added along with -9 volu mes of 
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distilled water to facilitate the separation of phases. The lower phase is 
collected, 0 . 1 \ b utyrated hydroxy toluene is added as preservative, and the 
solution is stored at 0-4 'c. 
Preparation of Upid Vesicles and Incorporation of Solubilized 
Membrane Fractions into Upid Vesicles 
To 50 mls of CH03 containing -50 mg crude lipids is added 1 0  mls of 
EtOH. The solution is then evaporated to dryness on a rotory evaporator. 
NeIt, 20 mls of benzene is added, and the solution is sonicated for 90 
seconds to resolubilize lipids. The lipid solution is transferreed to a 25ml  
round bottomed flask and is frozen in  dry ice/acetone before being 
lyophilized. For preparation of vesicles alone, dialysis buffer is added to dry 
lipids achieving a final concentration of 1 0 - 1 5  mg lipid/ml. OG is then added 
until the solution clarifies. Final concentration of OG is typically 3-4\.  
For the preparation of reconstituted vesicles containing axoiem mal 
proteins, one ml of the solubilized axolem m al fraction in 2\ OG, containing 
0 .5mg of solubilized protein, is added to approximately 1 0 - 1 5  mg of 
lyophilized lipids and then supplemental OG is added until solution clarifies. 
In both cases, vesicles form when OG is dialyzed against dialysis b uffer at 
0 -4 'e for 48 hours. The integrity of vesicles is  checked by incubating formed 
vesicles in hypotonic or hypertonic b uffer and observing an increase or a 
decrease in light scattering at 400nm signifying swelling or shr.in.k.age of 
vesicles respectively. 
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Results 
Establishment of Schwann Cell Growth Conditions 
Schwann Cells were prepared from the sciatic nerves of neonatal rats. 
In order to produce cultures which possessed the fewest fibroblasts and 
greatest numbers of Schwann cells, a compromise was reached concerning 
the timing of the sciatic nerve dissection. If newborn or one day old rat 
sciatic nerves were used, there was little connective tissue with its 
attendant fibroblasts, but the nerves were eltremely friable making 
dissection difficult and lowering the yield of viable Schwann cells. Although 
the sciatic nerves of 4-6 day old animals were larger, they contained 
elcessive connective tissue so that the resultant cultures contained greater 
numbers of fibroblasts. In order to muimize yield and minimize 
conta mination with fibroblasts, sciatic nerves of two day old animals were 
routinely used as a Schwann cell source. 
The rapidly proliferating fibroblasts in the primary culture which 
would tend to overgrow Schwann cells were selectively eliminated with the 
antimitotic agent, cytosine arabinoside ( ARA-C) which was added to all 
cultures 24  hours after plating. If ARA-C was added earlier, the cells 
tended to dissociate from the plates and die. A three day treatment was 
used to prevent Schwann cell damage and muimize elimination of 
fibroblasts. After ARA-C treatment, 85-90' of remaining cells had the 
typical spindle shaped appearance of Schwann cells. 
After ARA-C treatment, the remaining fibroblasts would proliferate 
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rapidly, and overrun the Schwann cells in  approximately one week, if 
given the opportunity (Table 1 ). 
The Thy- l . l  antigen is present on neural fibroblasts and was used in a 
complement mediated lysis (CML) to remove fibroblasts which remained 
after ARA -C treatment (Brockes 1 979b ). The timing of the anti-Thy 1 . 1  
treatment represented a compromise between allowing the Schwann cells 
to recover from ARA-C and preventing the proliferation of fibroblasts. The 
data from fluorescent staining experiments in table 1 shows that 3-4 days 
after ARA-C treatment, 6 8 \  of the cells are viable. Cultures remain free of 
fibroblasts up to 5 days after anti-Thy 1 . 1  treatment. Two days after 
ARA-C treatment, only 40\ of the cells excluded trypan blue. This suggests 
an increased susceptibility to damage from trypsin and mechanical 
disruption if the cells are treated sooner than three days after removal of 
ARA-C from the media. Six days after ARA-C treatment, 1 3 \  of the cells 
were stained with the anti-Thy 1 . 1  antibody. When these cultures were 
treated with the anti-Thy 1 . 1  CML, resultant cultures were only 99 .5\ 
pure. If cultures were allowed to grow for 8- 1 0  days prior to anti-Thy 1 . 1  
treatment, then fibroblasts had established relative supremacy; and the 
CML could no longer destroy all the fibroblasts. The presence of 
contaminating fibroblasts was reflected in increased control values in 
H3-thymidine u ptake experiments.(Table I )  These data show that even the 
presence of 0.5 \ contaminating fibroblasts causes a significant increase in 
the uptake of tritiated thymidine by control cultures. 
The source of complement was critical to the success of the CML 
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TABLE 1 
Fibroblast Contamination as a Function of the Length of 
Time Following ARA-C Treatment Prior to Anti-Thy 1 . 1 
Complement Mediated Lysis 
� � � CPM 
LenSLh oC tiae fibroblasts fibroblasts Typall blue 3D-Thyai-
.Cter remoTal PRIOR to AFTER eulusion .C- dine uptake 
oC AllA-C anti-Thy 1 . 1  anti-Thy 1 . 1  te r  anti-Thy after anti-
Croa culture CML CML 1 . 1  CML Thy 1 . 1  CML 
aediua (a) (II) ( c )  ( d )  • 
2 nays 6.0\ o . a  40.0\ 6 1 .0 
-f nays 1 3.0\ 0. 1 \ 68 .0\ 1 1 6.0 
6 nays 1 3.0\ 0 5 \ 60.0\ 3-47.0 
8 nays 28.0\ 1 .3 \  62 .0\ 322.0 
1 0  nays 6 1 .0\ 1 3.0\ 5 5.0\ 585 0 
Deter minations of \ fibroblasts were made as follows: ( anti-Thy 1 . 1  
positive cells/total cells) x 1 00. Counts were done -4 8  hours after anti-Thy 
1 . 1  treat ment. 
• Uptake of 3H -Thymidine was measured as described in methods 
section. Briefly, mitogens and 3H-Thymidine were added to cells one day 
after anti-Thy 1 . 1  treatment. Cells were harvested and counted -48 bours 
later. Results are expressed in counts per minute (CPM ). 
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procedure. Rabbit complement was most efficient, but there was great 
variability between lots. Attempts at CML using goat, rat, or mouse 
complement were universally unsuccessful. 
ImmunologiC Identification of Schwarm Cells and Fibroblasts 
The validity of the assay for Schwann cell proliferation depended on 
unambiguous identification of the two cell types present in cultures grown 
from sciatic nerve; i.e. fibroblasts and Schwann cells. Fibroblasts express 
the Thy ! . 1  antigen which is also found on astrocytes and on neurons, b ut 
not on ·Schwann cells (Broc.kes, 1 977). The Thy 1 . 1  antigen was utilized for 
both identification and cell specific CML of fibroblasts. Figure ( I )  shows a 
fibroblast labelled with the mouse anti-rat Thy 1 . 1  monoclonal antibody, 
(combined with an FITC conj ugated goat anti- mouse IgG)in the presence of 
unlabelled Schwann cells. Since only two cell types coexist in our cell 
cultures, and the anti Thy 1 . 1  antigen is found on > 80\ of neural 
fibroblasts,(Raff, 1 97 9 )  then cells which did not stain with anti Thy 1 . 1 
could usually be considered to be Schwann cells. 
Direct identification of Schwann cells was made possible using an 
antibody specific for the enzyme CNPase. Although the function of CNPase 
has not been determined, the enzy me has been utilized as a marker for 
myelin and uncompacted glial plasma me mbranes. ( Matthieuj.M., 1 98 0 )  
In  previous work, Schwann cells prepared from mouse and human tissue 
possessed CNPase activity.(Constantino-Ceccarini, 1 98 2 )  
The antibody to CNPase was a generous gift from Dr .  Terry J .  Sprinkle. 
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FIGURE J 
Indirect Immunofluorescence Anti-Thy 1 . 1 
StaJn1ng of a Fibroblast 
A B 
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AJ Phase contrast. The large fibroblast is identified by its polygonal 
shape and multiple processes. It is lying a mong several bipolar shaped 
Schwann cells. 
B.) Same field as A stained with antibody to Thy 1 . 1 .  Primary 
cultures of Schwann cells were replated onto coverslips. Two to seven days 
after replating, the cells were fued on the coverslips with ethanol and 
rehydrated with I "  bovine serum albumin in phosphate buffered saline. 
Antibody to the Thy 1 . 1  antigen was diluted 1 ->50 and incubated with 
cultures for 20 minutes at 37·C Fluorescein coupled goat anti-mouse IgG 
was diluted 1 ->30 and added to cultures for 30 minutes at 37·C 
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Schwann cells were recognized b y  their bipolar spindle shape and lack of 
anti Thy 1 . 1  immunoreactivity. When cultures stained with anti CNPase 
were exa mined with indirect i m m unofluorescence, only the spindle shaped 
cells fluoresced. Fig (2a) shows a phase micrograph of a field of Schwann 
cells lying on a single large fibroblast. Figure (2b) shows the same field 
stained with anti-CNPase exa mined using indirect i m munofluorescence; 
note the absence of fibroblast staining. Substituting pre-im mune seru m  for 
anti-CNPase abolished the specific staining as shown in figure (3) .  
CNPase was found to be a persistent marker for Schwann cells, being 
present on Schwann cells in culture for as long as three months. In 
addition, i m munological reactivity with CNPase was found on Schwann cell 
which had been stimulated by cholera toxin and had lost their typical 
spindle shape. This made possible the identification of Schwann cells even 
when they appeared virtually indistinguishable from fibroblasts. 
Measurement of Mitogenic AcUvit y 
We initially utilized radioautography to assess Schwann cell 
proliferation (Brockes, 1 980b; Wood, t 975; DeVries t 982) .  Background 
proliferation of Schwann cells was found to be 0.2-4.0', with the higher 
background proliferation being observed if cells were assayed less than t 2 
hours after replating. The data in table 2 reveal that Schwann cells show a 
mitogenic response to cholera toxin and oolem ma, as previously 
reported.(Cassel, 1 98 2 )  In addition, a mitogenic response was elicited in 
response to a myelin enriched fraction from rat brain. The absolute values 
for labelling indeles of the different mitogens were in agreement with 
FIGURE 2 
Indirect Immunofluorescence AnU-CNPase 
Staining of Schwann Cells 
A B 
38 
AJ Phase contrast. A nu mber of Schwann cells (SC) were identified by 
their bipolar and spindle shape morphology lying on a large fibroblast (F). 
B.) Same field as A stained with antibody to CNPase. Primary cultures 
of Schwann cells were replated onto coverslips. Two to seven days after 
replating, the cells were filed on the coverslips with ethanol and 
rehydrated with I "  bovine serum albumin in phosphate buffered saline. 
Antibody to bovine central nervous system CNPase was diluted 1 -)90 and 
incubated with the cultures for 20 minutes at 37°C. Fluorescein coupled 
goat anti-rabbit IgG was diluted 1 - ) 1 00 and added to the cultures for 30 
minutes at  37°C. 
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FIGURE 3 
Indirect Immunofluorescence Micrograph of a Schwann 
Cell Culture. Showing Absence of SpecifiC Staining 
Cells were prepared in the same manner as those in Figure 2. They 
were incubated with pre-immune serum diluted 1 - >50 for 20 minutes at 
37°C. Fluorescein coupled goat anti-rabbit IgG was diluted 1 -> 1 00 and 
added to the culture for 30 minutes at 37°C. The photograph was exposed 
for 2 minutes. 
TABLE 2 
Schwann Cell Mitogenic StimUlation 
Measured by Radioautography 
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LabellinR Index ( O J  Standard Deviation 
Control 1 :4 1  
AIolem ma 1 2.01 
( t Omg/ml) 
AIole mma 26.0 1 
(20 mg/ml) 
Myelin 28.01 
( I Omg/ml) 
Cholera TOIin 36.01 
( 1  mg/ml) 
"Labelling IndeI = Total # of Cells Labelled I 1 00 
Total # Cells 
8.01 
1 1 .01 
Cells were prepared in usual fashion and had been treated with anti-Thy 
1 . 1  CML .( days after ARA-C was withdrawn from culture media. 
Twenty-four hours after Thy 1 . 1  complement mediated lysis, cells were 
eIposed to both mitogens and 3H-Thymidine (SuCi/well). Forty-eight 
hours later, they were prepared for radioautography as described in the 
methods section. Cells were considered positive if they had greater than 
1 0  grains over the nucleus. At least SOO cells were counted for each cover 
slip. 
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published values (Cassel, 1 982;  De Vries, 1 983b).  Though this assay was 
reproducible, it was quite tedious in practice, and a more rapid assay was 
needed in order to begin a detailed analysis of Schwann cell proliferation. 
The Linbro microwell assay was developed for this purpose. The 
assay depended on the production of pure Schwann cell cultures so that 
measurement of thymidine uptake could be directly related to an increase 
in Schwann cell growth. The actual assay was a modification of the method 
used by Brockes (Brockes, 1 980b ). Background or control levels of 
H3-thymidine uptake could be related to Schwann cell purity as 
demonstrated in Table one. Control values for thymidine uptake remained 
low and assay was reproducible providing that CML was performed no 
later than 6 days after removal of ARA-C from cultures. 
Mitogenic Response to Cholera Toxin 
An increase in intracellular cAMP either directly, or indirectly, using 
cholera tOlin, had previously been shown to increase Schwann cell 
proliferation.The response of Schwann cells to cholera tOlin is reported in 
figure 4. Cholera tOlin is active in very small quantities; 0.5 picograms was 
sufficient to cause one-half maIimal stimulation of 1 0,OOO Schwann cells. 
Previous studies had used dosages of cholera tOlin in the microgram range, 
which is 1 00,OOO times the amount used in this study. 0.5 picograms is 
equal to 5.6" 1 0- 1 8  moles or ""3.3 million molecules. Thus, 330 molecules of 
cholera tOlin per cell elerts a one half maIimal mitogenic response. 
The maIimal response to cholera tOlin was 2 the response elicited by 
any of the other mitogens tested, including the aIolemma enriched fraction. 
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Cells were eIposed to varying doses of cholera tOIin in the presence of 
3H-Thymidine for 48 hours and then harvested for counting in the usual 
manner. All points are averages of quadruplicat.e deter minations. 
Standard deviations are indicated by bars surrounding data points. 
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As noted previously, cholera toxin induces marked changes in the 
morphology of Schwann cells. This will be discussed later. 
Mitogenic Response to the Axolemma Enriched Fraction 
The response of Schwann cells to the axolemma enriched fraction from 
rat central nervous system (CNS) is shown in figure 5. The dose response 
was linear in the range from 0.5-20 micrograms per mL At higher 
concentrations, the response diminished and there appeared to be some 
toxicity associated with dosages of axolem ma >40�g/ml I n  the linear 
range of the curve,the slope was approximately 60-70 cpm of tritiated 
thymidine incorporated/48h/�g axole m mal protein and the correlation 
coefficient was consistently 0 .98-0.99.  When Schwann cells were 
stimulated with axole m ma, they retained their spindle shape with long 
processes in contrast to cholera toxin stimulated cells which became 
flattened, wispy, had more than two processes, and closely resembled 
fibroblasts (Figure 6). The m aximal obtainable stimulation by axolem m a  
was not influenced by either the length of time between ARA-C treatment 
and anti-Thy 1 . 1  treatment or by the lapse in time after CML prior to 
stim ulation of cells. (Table 3 )  Note that 1 0  days after ARA -C treatment, the 
average maximal stimulation in thymidine u ptake is greater but that the 
variability in response is so great as to make results invalid. This 
variability is probably caused by the larger proportion of rapidly 
proliferating fibroblasts.(See table 1 )  In contrast, a delay of two weeks 
after a s uccessful anti-thy 1 . 1  treatment still yielded an experiment with a 
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Figure 5 
Dose D e pendent Mitogenic Response of Cultured 
Schwann Cells to the A x olemma l Mitogen 
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Cells were exposed to varying doses of axolemma in the presence of 
3H-Thymidine for 48 hours and then harvested for sCintillation counting in 
the usual manner. AU points are average of tripticate determinations. 
Standard deviations are indicated by the bars surrounding data points. 
FigUre 6 
Morphologic Response of Cultured Schwann 
Cells to Nitogens 
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Cells were either untreated ( A ), treated for five days with cholera 
tolin at I ug/ml (B),  or treated for 5 days with aIolemma at S ug/ml (e) 
AJ Untreated cells; typical spindle shaped bipolar cells aligned in fascicles. 
BJ Cholera tolin treated cells; cells have lost their bipolar shape and are 
flatter. They appear fibroblastic with prominant nuclei. CJ Alolemma 
treated cells; morphology resembles untreated untreated cells in A. 
Bar in each phase- micrograph represents l O um. 
TABLE 3 
Time After ARA -C Treatment vs. Nutmal 
Mitogenic StimUlation 
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Time Maximal Stimulation Standard Deviation 
(Days) (CPII - eoalrol CPIU (CPII) 
2 1 035  280 
3 1 000  500  
.. 1 1 1 3 277 
� 1 1 03  585  
6 1 665 1 290 
A 1 2 1 8  237 
1 0  3552 2046 
Time After Anti-Thy 1 . 1  CML vs. Maximal 
MitogeniC Stimulation 
Time Maximal Stimulation Standard Deviation 
(Bollrs) (CPII S .. ,le - CPII eoatroI) (CPII) 
I A  1 256 375 
20 1 1 08  240 
24 1 1 59  387 
30 1 248 485 
4A 1 048 433 
2 weeks 1 425 800 
The time afLer ARA-C treatment corresponds to the time interval betveen ARA-C 
treatment and the anti-Thy 1 . 1  CML. Time afLer anti-Thy 1 . 1  CML is the time interval 
from anti-Thy 1 . 1 CML to the beginning of stimulation experiments. 
Maximal stimulation is expressed as sample CPM-Control CPM rather than as 
stimulation index to allow direct comparison betveen experiments with different 
control values. The maximal stimulation was in response to challenge with 20 mg/ml 
axolemmal mitogen during a <48 hour incubation with 3H-Thymidine. 
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b ackground of only 1 6 8  cpm and a maximal 9 fold stimulation in the 
presence of axole m ma, indicating both a relatively complete and lasting 
elimination of fibroblasts by anti Thy l . 1  CML and the ability of Schwann 
cells to respond to mitogenic stimulation even after a two week period of 
quiesence. 
Distribution of Mitogenic ACtiVity within the Sucrose Denstt y 
Gra.dient 
Earlier studies of the distribution of membrane bound mitogenic 
activity in different membrane fractions have produced confusing results. 
In eIperiments with dorsal root ganglion derived Schwann cells, Cassel et 
al found maximal mitogenic activity in an axolem mal fraction which was 
characterized by enrichment in the enzyme markers, acetylcholine esterase 
( AChE) and sodium -potassiu m  ATPase. However, the whole homogenate of 
brain contained 64\ maximal actiytiy. The myelin enriched fraction, 
characterized by increased CNPase and myelin basic protein 
im munoreactivity had mitogenic specific activity only 1 3 \  as great as that 
in the axolem m al fraction.(Cassel, 1 98 2 )  
In eIperiments using Schwann ceJJs derived from sciatic nerve, 
DeVries et al found maximal mitogenic activity in whole homogenate with 
the axolem mal fraction possessing 76\ of the maximal specific activity 
present in the whole homogenate. The myelin enriched fraction yielded 
approIimately one half of the specific activity of the axolemma enriched 
fraction.(DeVries, I 983)  
We repeated these eIperiments analyzing additional discreet 
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me mbrane fractions from a 1 0-40" continuous sucrose gradient. The 
results of a representative experiment are presented in figure ( 7 ) . As 
noted in previously cited experiments , the whole brain homogenate(WH ) 
had significant mitogenic activity, stimulating a ten fold increase in 
thymidine uptake by Schwann cells as compared with control values. I n  
addition, shocked myelinated axons (SMA) contained nearly a s  m uch 
mitogenic activity as the WHo SMA are prepared by osmotically shocking 
and mechanically disrupting the portion of the whole homogenate which 
" f1oats up" during an 82,000 x g centrifugation in 1 .0 M sucrose. The SMA 
is enriched in the enzyme markers CNPase and AChE as compared with the 
WH b ut the specific mitogenic activity per mg membrane protein is 
somewhat reduced. This decrease in mitogenic activity suggests that either 
membranes or soluble material which is mitogenic is lost in the 82,000 x g 
centrifugation or that the activity is destroyed by the mechanical 
disruption used during the preparation. Mechanical disruption in the for m 
of sonication has been shown to destroy completely the axole m mal 
mitogenic activity after a 3 minute treatment. (DeVries, 1 983)  In the 
preparation of SMA, the me mbranes are subjected to treatment with a 
Tek mar tissue mizer for 60 seconds. This disruption causes significant 
shearing of the myelin sheath from the axonal plasma me mbrane, 
providing for separation of the me mbrane fractions during subsequent 
sucrose gradient centrifugation, but potentially disrupting membrane 
orientations required for the expression of the mitogenic signal. In 
addition, the float up procedure used to prepare SMA selects for myelin 
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FIgure 7 
Distribution of Mitogenic A ctivity In Membrane 
Enriched Fractions Derived from R a t  B r a l  n 
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WH SMA 10-20'. 21-271. 28-32'. 33-38% 
The preparation of membrane fractions is described in the methods 
section. Briefly, CNS white matter is homogenized in buffered isotonic 
NaG-sucrose solution to make the whole homogenate (WH). The WH 
undergoes a "float up" procedure which separates the lighter myelin 
associated elements from membrane components with greater specific 
activity. The resultant fraction is isotonically shocked and then 
homogenized yielding the shocked myelinated axon fraction (SMA). 
The SMA is then fractionated on a continuous sucrose gradient and 
portions of the gradient were pooled to yield fractions corresponding to 
1 0- 1 9� ,  2 1 -27�, 28-32�,  and 33-38� sucrose. (w/v) The 1 0- 1 9� and 
28-32\ fractions were designated myelin and axolemma enriched 
fractions, respectively. Samples were used within 24 hours or were frozen 
at -70 ·C and then thawed just prior to use. 
Mitogenic activity is expressed as CPMsample/CPMcontrol. Each 
sample was tested over a range of dosages and results are reported at 
20 �g/ml protein concentration which yielded maximal activity for both 
myelin and axolemma enriched fractions. All enzyme activities were 
determined within 1 6  hours of the preparation of samples. 
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and those alons which are associated with myelin. Any free alons would 
not float up and would be lost during the preparation of the SMA. 
The malimal specific mitogenic activity (cpm/mg protein/48 hours) 
was found in the alolemma enriched fraction and was characterized by 
high AChE activity and relatively low CNPase specific activity. There was, 
however, significant mitogenic activity found in all parts of the gradient. 
This spectrum of activity elibited a bimodal appearance. There was a peak 
of activity in the 1 0-20\ fraction which in earlier studies had been found 
to contain tightly packed multilamellar myelin. It was not, however, the 
fraction containing the highest specific activity of CNPase. Even though 
CNPase has been used as a marker for myelin, the lack of coincedence of 
morphologically identifiable multilamellar myelin and CNPase enzyme 
activity has been observed by other workers using a 1 0-40\ continuous 
gradient for separation of brain membranes (Shapira, 1 978). Thus, it 
appears that CNPase activity resides with loosely packed myelin and glial 
cell plasma membranes and that the myelin associated mitogenic activity is 
greatest in the fraction containing tightly packed multilamellar myelin 
which is low in CNPase activity. 
The observed spread in mitogenic activity could be accounted for by 
contamination of other membrane fractions by axonal membranes. This 
possibility is unlikely based on the unequal distribution of the axonal 
enzyme marker, AChE. If AChe and the mitogenic signal reside in the same 
membrane, then their activities should comigrate, which they do not. 
Thus, it appears that there could be two distinct mitogenic signals 
5 1  
partially separated on the gradient. One being associated with 
multilamellar myelin and the other with the axolemmal membrane. 
Comparison of the MitogeniC Activity from Axolemma and 
Myelin Enriched Fra.ctions 
The distribution of mitogenic activity across the sucrose gradient 
suggested that there may be indeed two distinct mitogenic signals located 
in the aIolemma and myelin enriched fractions. We set out to determine 
the properties of the two proposed signals to see if there were discernible 
differances. 
The dose response curves for the myelin and aIolemma enriched 
fractions are presented in figure ( 8 ). Both fractions elicited a linear 
response of Schwann cell proliferation to increasing dosages from 0.5 to 20 
�g/ml and actually had very similar specific activities. The myelin 
enriched fraction did seem to exert a toxic effect at lower dosages than the 
aIolem m al fraction. 
Salzer et al found that freezing and thawing the neurite mitogen 
abolished its activity but in previous work with the axolemmal mitogen, 
DeVries et al found that freezing and thawing did not significantly alter 
mitogenic activity. We found that 3 cycles of freezing and thawing the 
axolemmal mitogen caused it to lose approximately 33" of its activity. 
Conversely, the same treatment caused no loss of myelin associated 
mitogenic activity and actually seemed to enhance the response, though the 
results were not statistically significant. Thus, the axolemmal mitogen 
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Ftgure 8 
Dose Dependent Mitogenic Response of Cultured Schwann 
Cel ls to A x olemma and Myelin Enriched F r a c t ions 
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MEMBRANE PROTEIN (ug/ml) 
Cells were elposed to alolem ma or myelin enriched membrane 
fractions in the presence of 3H-thymidine for <48 hours and then harvested 
for counting in the usual manner. Standard deviations are indicated by the 
bars surrounding data points. 
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appeared to be more sensitive to either the thermal or mechanical stresses 
involved in freezing and thawing. 
Previous studies have shown that the aIolem mal mitogen is sensitive 
to heat ( DeVries, 1 983 ). When the aIolem mal and myelin fractions were 
subjected to heat treatments, some striking differances appeared. The 
affect of incubating aIolem mal fractions for ten minutes at different 
tempertures is shown in Figure ( 9 ). Clearly, prolonged incubations at 8 0 'C 
inactivated the aIolem mal mitogen. Similar treatment of the myelin 
enriched fraction failed to reveal any decrease in activity even at l OO 'C for 
ten minutes. 
Since it was possible that the mitogenic activity was in a more 
protected environment in the myelin enriched fraction, we treated the 
myelin for prolonged periods of time at 80·C. The combined results of four 
experiments are presented in figure ( 1 0 ). The data show that the 
axolem mal fraction quickly loses its activity at 80'C as expected.  In 
contrast, the myelin associated activity is actually significantly enhanced 
by incubation at 80'C for up to two hours. This data suggested that the 
signals were indeed different, and that the myelin associated activity might 
not even be an active protein, since under denaturing conditions, the 
activity persisted. 
Trypsin, a proteolytic enzyme, is known to abolish the axolem mal 
mitogen when used in low concentrations for short periods of time. (Salzer 
1 980c; DeVries, 1 983)  This information in combination with heat 
Ftgure 9 
Effect o f  Timed Incuba tion a t  Increasing 
Tem pe r a t u r e  on the Mitogenic Activity 
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35 40 45 50 55 60 65 70 75 80 
TEMPERATURE ("C) 
Membrane fractions were heated for 10 minutes at the indicated 
temperatures, miIed on a VorteI miIer before being cooled, and then 
added to Schwann cell cultures. All determinations were done using 20 
IJ.g/ml of aIoiemma. Cells were incubated with aIoiemma and 
3H-Thymidine for 48 hours before harvesting. 
Standard deviations are indicated by bars surrounding data points. 
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Ftgure 1 0  
Effect of Prolonged E x p o s u r e  t o  H e a t  on the M i t o g e n i c  
A c tivity of A x olemmal a n d  Myelin Enrich ed Fractions 
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Each membrance fraction was incubated at 800C for a designated 
length of time. Samples and 3H-Thymidine were then added to Schwann 
cells. After 48 hours, cells were harvested and counted. The results are 
elpressed as: 
% AcUv1ty 
CPM Membrane Sample - CPM Control 
CPM Untreated Sample - CPM Control 
All data points are the mean of nine determinations. 
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sensitivity data was used to suggest that the aIolemmal mitogen was a 
polypeptide. Since the myelin associated activity was not heat sensitive, it 
seemed possible that it might also be resistant to proteolytic treatment. We 
compared the susceptibility of the aIolemmal and myelin enriched 
fractions to the action of trypsin. As shown in table 4, the aIolem mal 
activity is reduced to 1 2' of control activity after trypsin treatment but is 
preserved if soybean trypsin inhibitor is added to the incubation mediu m. 
In contrast, treatment with 0 .05\ trypsin for one hour did not significantly 
decrease the mitogenic activity of the myelin fraction. 
The above data supported the notion that the aIolemmal mitogenic 
signal was a protein on the basis if its susceptibility to heat denaturation 
and proteolytic digestion. In fact, the mild trypsin treatment used in our 
experiments has been shown by Salzer to preserve the integrity of 
membranes (Salzer 1 980a). Thus, any activity destroyed by trypsin 
digestion was probably located on the external surface of the axolemmal 
vesicles. 
Glycoproteins have been identified as cell to cell recognition factors 
and are located consistently on external cell surfaces. If the axolem mal 
mitogen were a glycoprotein, it should be susceptible to the action of either 
trypsin or an endoglycosidase. We treated the axolemma and myelin 
enriched fractions with endoglycosidase D. The reaction catalyzed by this 
enzyme is diagrammed in figure ( 1 1 ). Basically, the enzyme removes a 
portion of the sugar group from susceptible glycopeptides and 
glycoproteins. Thus, if the mitogenic signal were inhibited by treatment 
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TABLE 4 
Effect of Trypsin on the Mitogenic Activity of 
Al::olemmal and Myelin Enriched FracUons 
Control Trypsin Trypsin Soybean Trypsin 
O.05S and STI Inhibitor (STI)  
AIole m ma: 
zou" at 
S • 1 00 \  1 2 \  1 1 6\  1 25 \  
CPM 797 1 88 906 972 
Myelin: 
20 u,l.l 
S • 1 00 \  9 5 \  1 33 \  1 29 \  
CPM 573 552 729 7 1 2  
Trypsin treatment is described in the material and methods section. 
Schwann cells were prepared in the usual fashion. The various mitogens 
and 3H-Thymidine were added to Schwann cells and incubated at 370C for 
48 hours prior to harvesting and scintillation counting. 
Both Axo1emmal and Myelin derived fractions were used at dosages 
which gave maximal response prior to Trypsin treatment (20 ug/mll. 
• Percent of controlled activity 
58 
FIgUre 1 1  
Reaction Catalyzed by Endoglycosidase D 
(Man)3GlcNAc-GlcNAc-peptide --) (Man )3GlcNAc + 
I 
FUc Fuc-GIcNAc-peptide 
The enzyme is an endo-beta-N-acetylglucosaminidase which cleaves 
the core di-N-acetylchitobiose linkage of mannosyl glycoproteins. 
Endoglycosidase D requires the presence of an exposed alpha-mannosyl 
residue for optimal activity and, therefore, acts preferentially on complex 
carbohydrate chains as opposed to high mannose chains. (Tai, T., et aI, 
1 975) 
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with endoglyco5ida5e D, it would not only support the notion that the 
mitogen is a glycoprotein, it would also help to define the structure of the 
sugar portion of the glycoprotein. 
In preliminary work with endoglycosidase D, treatment with 40 mU of 
the endoglycosidase for 1 2H resulted in total los5 of mitogenic activity in 
the alolemma enriched fraction but no loss of myelin associated mitogenic 
activity. The results indicate that the alolem mal mitogen may be a 
glycoprotein, and again reveal a difference between the alolemmal and the 
myelin associated mitogenic activities.  
Finally, we observed that Schwann cells stimulated with the alolem ma 
enriched fraction appeared quite different from cells stimulated by myelin. 
As shown in figure ( 1 2  ) the alolem ma stimulated cells maintained their 
bipolar spindle shape and seemed to have a s mall quantity of particulate 
matter adherent to their outer surfaces. Also, they grew in small clu mps 
and often alligned themselves along their bipolar alis. In contrast, cells 
stimulated with myelin at the same dosage appeared to be covered with 
particulate matter clinging to cell surfaces. In addition, many of the myelin 
stimulated Schwann cells contained larger vacuoles that appeared 
intracellular. Neither myelin or alolem ma elicited the morphologic changes 
observed when cells were stimulated with cholera toxin. (See Figure 1 2  and 
figure 5 )  
60 
Figure 1 2  
Appearance of Schwann Cells During Stimulation by 
Either Axolemma or Myelin Enriched Membrane Fractions 
A B 
(AJ Cells stimulated with aIole m ma (20�g/m!) appear in clu m ps 
with their bipolar axis aligned .  There is particulate matter adherent to 
many of the cells. giving rise to a granular appearance. 
(BJ Cells in the presence of myelin (20�8/ml) are nearly hidden by 
the ab undant a morphous membrane frag ments. The cells are more spread 
out and individual cells often appear covered with particulate matter. 
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Schwann Cell Proliferation Induced By Membrane Fractions 
From Other Sources 
In a previous study of Schwann ceU proliferation, DeVries et al found 
that rat dorsal root ganglion Schwann ceUs responded to axolemma from 
both eNS and PNS. In addition, rat Schwann ceUs responded to an 
axolem ma enriched fraction from bovine CNS (DeVries, 1 98 2 ). We repeated 
this work to confirm the results in Schwann ceUs derived from sciatic 
nerve. Figure ( 1 3  ) shows a comparison of the maximal response of PNS 
and CNS rat axolemma enriched fractions as well as representative data 
from experiments with bovine and human CNS axolemma enriched 
fractions. Though axolem mal fractions from both the CNS and PNS 
stimulated Schwann cell proliferation, the PNS samples resulted in 
consistently lower maximal response. The dose response to both CNS and 
PNS fractions was linear from 1 -30 llg/m I. 
The axolemmal fractions from rat, bovine and human CNS all actively 
stimulated Schwann cell division. Although the data appear to suggest that 
hum an axolemma is the most potent mitogen, 2011g/ml of human material 
were used in comparison with only 1 5  llg/ml of rat axolemmal fraction. 
The specific mitogenic activity expressed as: 
(CPMsample/CPMcontrol )/llg protein/48 hours 
was 2 4.6 for rat axolemma vs 25.8 for human axolemma which is not 
significantly different. 
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Ftgure 1 3  
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Schwann cells were prepared in the usual manner and then exposed 
to membrane fractions in combination with 3H-thymidine for 48 hours, 
prior to harvesting. Me mbrane fractions were used at the indicated 
protein concentrations. The rat PNS alolem ma was prepared from sciatic 
nerve according to the method of Yoshino. (Yoshino, 1 983)  
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Axolemma Enriched Fractions From Multiple Sclerosis Plaque 
Stimulate Schwann Cell Proliferation 
MS produces plaques in human white matter consisting of 
demyelinated &Ions, astroglial hyperplasia, and lymphocytic infiltration. 
There is a relative paucity of functional oligodendroglial cells which are 
the cells that produce myelin in the CNS and are therefore analogous to 
Schwann cells. Thus far, no specific physiological defects or tolic factors 
have been identified in MS plaques to account for the observed 
demyelination. We investigated the mitogenic effect of aIolemma enriched 
fractions from nor mal CNS white matter and from MS plaque. Surprisingly, 
the material derived from MS plaque resulted in significantly greater 
Schwann cell stimulation than did the aIolemmal fraction from normal 
brain at all dosages tested, in four separate elperiments.(See figure 1 4  ) 
The mitogeniC activity found in MS plaque was capable of approlimately a 
1 0  fold stimulation of proliferation comparing favorably with the most 
active rat CNS alolem mal fractions. There was no difference in the 
morphological response of Schwann cells treated with aIolemma from 
normal brain or MS plaque. 
Is the Schwann Cell Proliferative Response Specific? 
As reported by Pleasure et ai, Schwann cells do not proliferate in 
isolation or in contact with fibroblasts. In addition, dorsal root ganglion 
derived Schwann cells did not proliferate in response to membrane derived 
fractions from fibroblasts or 3T3 cells.( Salzer 1 980b. ) We wished to 
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FigUre 1 4  
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Alole m mal enriched fractions from normal hu man CNS white matter ( A )  or 
multiple sclerosis plaque (B) were prepared as described in the methods 
section. Cells were elposed to varying doses of the membrane fractions in 
the presence of 3H-thymidine for 18 hours and then harvested for 
scintillation counting in the usual manner. AU points are the average of 
triplicate deter minations. Standard deviations are indicated by the bars 
surrounding data points. 
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determine whether the mitogenic response was specific to brain 
membranes. Whole membrane fractions from liver, spleen, lung, and 
kidney of rats were added to Schwann cell cultures. In comparison with 
rat whole brain homogenate, no significant stimulation was observed with 
any of these fractions using up to 20 �g/ml of membrane protein. 
Stimulation of Oligodendroglia! Proliferation 
Alolem mal membranes from CNS caused proliferation of Schwann 
cells. Schwann cells are the myelin producing cells from the PNS. It seemed 
reasonable, therefore, that CNS aIole mma might cause proliferation of 
oligodendrocytes which are the CNS counterparts of Schwann cells. We 
prepared oligodendrocytes as previously described. ( McCarthy and 
DeVellis, 1 980)  All attempts, however, to promote increased proliferation 
of oligodendrocytes using either aIolem ma enriched fractions or cholera 
tOlin were unsuccessful. These results are consistent with the results of 
Pruss et ai, who found no mitogenic stimulus for oligodendrocytes. 
(Pruss, 1 982 ) 
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SoIubillZation and Extraction of the Axolemmal Mitogen 
In  order to begin an isolation of the axolem mal mitogen. we attempted 
to extract the mitogen from the membrane in an active form. Previously. 
attempts had been made to remove the mitogenic activity under conditions 
which would remove loosely associated membrane proteins. Specifically. 
Cassel et al attempted incubations in high and low ionic strength b uffers. 
chelation of divalent ions and incubation at pH 8- 1 0  ( Cassel. 1 982) .  These 
efforts were entirely unsuccessful in releasing the mitogenic activity. 
therefore detergent solubilization was attempted. assuming that the 
mitogenic signal was an integral membrane bound protein. Cassel was able 
to extract approximately 33\  of mitogenic activity using deoxycholate but 
results were erratic and solubilization was successful in only 50\  of 
experiments. 
We initially repeated Cassel's work with an attempt at extraction of 
mitogenic activity under conditions of high ionic strength. In this work. the 
axolem m al fraction was incubated with b uffers containing from 0.1 to 3.2M 
NaG and then centrifuged at 1 00.000 x g for one hour. The supernatant 
was added to Schwann cell cultures but no increase in proliferation was 
observed. and in fact the high salt concentration tended to make the cells 
float up in the wells invalidating the assay. 
Next, we began the detergent solubilization experiments using 
deoxycholate(DOC). cholate. and B-D-octylglucopyranoside (OG) as described 
in the methods section. DOC and cholate failed to solubilize any active 
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mitogenic activity under our elperimental conditions wheras treatment 
with 2\ OG for 30 minutes resulted in the solubilization of about 50\  of the 
mitogenic activity in close to half of the elperiments. Figure ( 1 5.)  portrays 
the results of one such elperiment. In this case, the aIolemmal fraction 
was initially solubilized in 2 \  OG for 30 minutes and then centrifuged at 
30psi C300,OOO I g) for 1 0  minutes in a Beckman airfuge. The resulting 
solubilized material contained approlimately 40" of the protein and was 
dialyzed against 40 volumes of 0 .05\ OG in b uffer. Concurrently, another 
sample of aIolemma without any detergent was dialyzed against b uffer 
containing no OG. The solubilized aIolem mal mitogen yielded 50\ activity 
at all dosages tested as compared with alolem ma not elposed to detergent. 
HF containing 0 . 1  \ OG did not stimulate Schwann cell proliferation . 
The solubilized sample was frozen at -20'C for three days and then 
reassayed at which time it had lost all activity. Similarly, storage of other 
active solubilized samples at 0-4'C or at -70'C resulted in total loss of 
activity. 
Since the solubilization results were so erratic, a search was made for 
complicating factors. First, we sought a proteinase which might be released 
during the solubilization procedure and which could destroy the mitogenic 
activity, accounting for the observed lability of the signal. An azocasein 
assay for proteolytic activity, however, failed to reveal proteolytic activity 
in either the crude alolem mal fraction or in the solubilized preparation. In 
their efforts at solubilization, Cassel et al had found a proteolytic activity 
released during solubilization of membranes that could be inhibited by a 
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FigUre 1 5  
Mitogenic Response of Cultured Schwann Cells to an 
Axolemma Enriched Fraction Solubll 14ed with Octylglucoslde 
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Cells were prepared in the usual manner and then incubated with 
membrane samples and 3H-thymidine for 48 hours prior to harvesting. 
The solubilization is described in the methods section. Briefly, alolem mal 
membranes were solubilized in I '  octyJ.glucoside and centrifuged. Then, 
the supernatant was dialyzed against b uffer for 48 hours (a) .  Control 
membranes were either untreated (b )  or were dialyzed without elposure 
to octylglucoside (c). OctyJ.glucoside alone did not stimulate Schwann cell 
mitosis. Protein determinations were done after dialysis. 
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preincubation of aIolemma at pH 1 0  in borate b uffer.{Cassel, 1 98 2 )  When 
we used this technique, approlimately 50'  of native mitogenic activity 
was again observed in the solubilized fraction. The stability of this sample, 
however was not checked. 
Alternatively, the instability of the solubilized aIolemmal mitogen was 
hypothesized to result from loss of surrounding lipid architecture. We tried 
to reconstitute the mitogenic signal in lipid vesicles as follows. Lipids were 
eltracted from whole rat brain and then an aliquot was solubilized in 5 '  
00. By slowly dialyzing away the 00, vesicles were allowed to form at 0-4·C 
(Paraschos, 1 982 ). The integrity of the vesicles was confirmed by observing 
an increase or decrease in light scattering of the vesicle suspension in 
response to hypotonic or hypertonic buffers, respectively. In a 
reconstitution elperiment, the solubilized lipids were combined with 
solubilized alolemma prior to dialysis. The vesicles thus formed were 
assumed to contain the mitogenic signal and did in fact contain 
approlimately 40' of the protein contained in the solubilized fraction prior 
to addition to the lipid solution. 
The results of a preliminary elperiment using reconstituted lipid 
vesicles is shown in figure ( 1 6  ). Unfortunately, vesicles caused only a 1 .5 
fold stimulation which was arguably significant. Liposomes alone resulted 
in no stimulation and actually inhibited thymidine uptake at higher 
dosages. 
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Figure 1 6  
The Prol iferative R e sponse of Cultured Schwann Cells t o  
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PROTEIN CONCENTRATION O F  SAMPLES (,IJg/ml) 
Cells were prepared in the usual manner and then exposed to 
mitogens and 3H-thymidine for 48 hours prior to harvesting. The 
preparation of brain lipid vesicles incorporating solubilized aIolemma is 
described in the methods section. 
This figure compares untreated aIolem ma ( a) ,  vesicles containing 
solubilized aIolem ma ( b ), and vesicles alone (c). Vesicles not containing 
aIolemmal protein were added such that the final concentration of lipid 
was the same as that in an equivalent volume of reconstituted vesicles. 
Lipid vesicles exert a significant inhibitory eCCect on 3H-thymidine uptake. 
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. Discussion 
In this discussion, I will consider Schwann cell proliferation in tissue 
culture in response to brain membrane fractions in the contert of the 
literature on Schwann cell proliferation. I shall discuss the finding of two 
distinct and characteristically different mitogens derived from compact 
myelin and arolemma, respectively. I will comment on preliminary efforts 
to extract and purify the arolemmal membrane bound mitogen. I will also 
comment on the finding that, not only does CNS arolemma stimulate 
Schwann cell proliferation, b ut an arolem ma fraction derived from MS 
plaque also stimulates Schwann cell division, and does so more efficiently. 
Preparation of purified Schwann cell cultures 
We prepared pure Schwann cell cultures from newborn rat sciatic 
nerve, making possible the assay of potential mitogens. Several other 
methods for the preparation of purified Schwann cells have been 
described, but each of them has significant disadvantages that made them 
less suited to our needs. 
Bunge, et al have studied Schwann cells derived from dorsal root 
ganglia (WOOd, 1 97 5 ). Briefly, dorsal root ganglia erplants are cultured in 
the presence of the antimitotic agents cytosine arabinoside (ARA-C) and 
f1uorodeoryuridine (FdU) to inhibit fibroblast growth. When the 
antimitotic agents are removed, the resultant erplants yield both a viable 
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ganglia of neurons with neuritic processes, and a "bed" of Schwann cells 
which emanate from the ganglia. 
If the ganglia are elcised, a relatively pure bed of Schwann cells 
results. This method allows recombination of neurites and Schwann cells 
and has made possible the study of myelination in vitro (Salzer, I 980al.  
However, the dorsal root ganglion culture method takes up to 3 weeks to 
produce a "bed" of pure Schwann cells and requires specialized growth 
media containing 25\  human placental seru m, 1 0\ chick embryo eltract, 
and nerve growth factor. Though tedious, this method has produced much 
information about Schwann cell growth and development, and has 
demonstrated that quiescent Schwann cells can be elposed to up to 6 days 
of treatment with ARA-C and still be able to proliferate and to 
differentiate. 
In an effort to rapidly and simply prepare larger quantities of 
relatively pure Schwann cells, Pleasure et al have utilized differential 
adhesion to produce 9 5 \  pure Schwann cells from neonatal rat sciatic 
nerve (Kreider, 1 98 1 l. Briefly, after mechancial and proteolytic disruption 
of sciatic nerves, dissociated cells are allowed to settle on poly-lysine 
coated dishes with intermittent shaking. After 1 8  hours, the non-adherent 
cells are removed. The authors state that > 9 5 \  of those cells are Schwann 
cells based on morphology and immunofluorescent staining with 
anti-galactocerebroside and anti-P2 Basic Protein. 
This method allows the preparation of about 1 I 1 06 purified Schwann 
cells from 20 neonatal rats in 48 hours. It avoids the use of anti-mitotic 
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agents or  complement mediated lysis (CML) but it  yields cultures only 9 , ",  
pure. Anti-mitotic agents, however, did not incapacitate Schwann cells in 
Bunge's work and, as will be seen later, CML allows specific targeting of 
cytolysis. So, the avoidance of these agents may be unnecessary. Finally, 
the presence of , "'  contaminating fibroblasts makes a thymidine uptake 
assay of Schwann cell proliferation difficult to interpret because rapidly 
proliferating fibroblasts take up a large quantity of 3H-Thymidine and 
thereby give rise to large and fluctuating control values. We have found 
that cultures with ,"' fibroblasts will become overrun with fibroblasts 
within 2 weeks. (see Table I) Though this method offers simplicity, speed 
and high cellular yields, it is fatally flawed by incomplete purification of 
Schwann cells. 
Brockes prepared purified Schwann cells from neonatal rat sciatic 
nerve using antimitotic agents and anti-Thy I . l  CML to produce cultures 
that are > 99.' ", pure.(Brockes, 1 979)  After dissociation, Schwann cells are 
eIposed to ARA-C for 2-3 days and then stimulated to divide with both a 
pituitary glial growth factor and cholera tOIin.(Brockes, I 980) At 3 - 1 0  
D.I .V. ,  any remaining fibroblasts are eliminated using anti-Thy I . l  
complement mediated lysis. 
This method produces essentially pure Schwann cells which are 
identified on the basis of their shape and the presence of the RAN- I 
antigen (Brockes, 1 977) It offers the advantages of speed and relative 
simplicity as compared with the dorsal root ganglion culture technique. 
However, Brockes stimulates his cells with the non-physiologic mitogen 
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cholera tOlin, and this induces a dramatic morphological 
transformation.(See figure 5 )  
We have prepared Schwann cells using this method and have found 
that cells elposed to cholera tOlin for over one week and then allowed to 
recover for up to two weeks (on media alone) no longer responded to the 
aIolemmal mitogen. Therefore, we do not stimulate Schwann cells with 
cholera tOlin prior to proliferation studies. 
The anti-thy 1 . 1  CML procedure used in our preparation has been 
criticized as potentially damaging to Schwann cells. (Krieder 1 982 )  The 
CML procedure, however, is very specifically targeted to those cells 
elpressing the Thy 1 . 1  antigen. Schwann cells do not elpress Thy 1 . 1  
(Raff, 1 979)  Using vivid time-lapse photography, DuBois-Dalcq has 
demonstrated that during anti-Thy 1 . 1  CML there is destruction of 
fibroblasts but no apparent damage to neighboring Schwann cells. 
(Dubois-Dalcq 1 9 8  t )  
In summary, preparation of Schwann cells from neonatal rat sciatic 
nerve employing both antimitotic agents and anti-Thy 1 . 1  CML b ut 
avoiding cholera tOlin results in cultures of Schwann cells that are > 99 .5\  
pure and which respond to the physiologic aIolem m al mitogen. This 
method allows the preparation of 1 .5 I 1 06 pure Schwann cells from 20  
rats in  about 9 days. The cells can be  stimulated to proliferate, can be 
passaged, and remain viable for at least 3 months. 
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IdentificaUon of Schwann CellS 
The unambiguous identification of Schwann cells in culture has been 
approached using morphologic and immunological methods. However ,  
Schwann cells can undergo dramatic morphologic changes during 
proliferation which mue them virtually indistinguishable from fibroblasts 
in culture (see figure S ). 
To alleviate this potential problem, Schwann cells have been 
identified by the presence of the myelin associated glycolipids, 
galactocerebroside and sulfatide (Ranscht, I 982 and Mirsky, 1 98 0 ). 
However, these lipids are not detectable on Schwann cells after " days in 
culture. Brodes used a monoclonal antibody specific for Schwann cells 
which was stable in culture. This antibody, however, is no longer available, 
and the deter minant for the antibody was never discovered. 
(Brockes, I 977) 
We have identified Schwann cells on the basis of the presence of 
2 ',3 '-cycJic nucleotide 3 '-phosphodiesterase ( CNPase ). The enzyme was first 
described in bovine pancreas and spleen, but was most concentrated in 
neural tissue.(Drum mond, 1 9 6 2 )  Although the physiologic function of this 
enzy me is unknown, it has been used as a marker for myelin and 
uncompacted glial plasma membranes.O::urihara, I 967 and Mattieu, 1 980)  
Previous studies have shown that cultured Schwann cells from mouse 
and hu man tissue possessed CNPase activity. (Constantino-Ceccarini, 1 982 
and ReddY, 1 9 8 2 )  We found that Schwann cells derived from rat sciatic 
nerve also have enzymatic activity and stain with an antibody specific for 
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CNPase. CNPase is present for up to 3 months in culture and, therefore, is 
not dependent on an axonal stimulus for its expression. CNPase is not 
present in fibroblasts. CNPase is, therefore, a stable and specific marker 
for cultured Schwann cells, and allows for their unambiguous identification 
in cell culture. 
Axonal and Myelin ASSOCiated Schwann Cells Mit<>gens 
Schwann cells proliferate first during embryonic development prior to 
differentiation and myelination. This period of proliferation is dependent 
upon an axonal stimulus. After myelination, Schwann cells remain 
quiescent unless there is nerve damage. With nerve injury, there is a 
second wave of Schwann cell proliferation and dedifferentiation which is 
independent of contact with viable alons. A third pulse of proliferation 
commences when alons grow bad: into a bed of waiting Schwann cells. 
This is followed by a second round of differentiation and myelination, 
completing the nerve repair. 
During both embryonic development and regeneration after nerve 
injury, Schwann cell proliferation is dependent upon an lUonal stimulus. 
As discussed in the introduction, there is ample in vivo and in vitro 
evidence for neuronal control of Schwann cell proliferation during 
development. In work with regeneration of amphibian limbs, nerve supply 
was critical for regeneration to occur from blastemal cells in the limb 
stump (Brockes, 1 98 4 ). Blastemal cells arise from dedifferentiation of 
mature Schwann cells and other cell types. With nerve growth into the 
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prolimal limb stump, there is proliferation and then differentiation of 
blastemal cells into Schwann cells and other cell types resulting in an intact 
limb (Brockes, 1 984 ).Thus, the process of proliferation, differentiation and 
myelination is repeated after nerve injury just as in development. 
Our culture system utilizes Schwann cells from three day old rat 
sciatic nerve, many of which had been myelin competent. When cultured, 
however, these cells become quiescent and no longer elpress myelin 
associated glycolipids. They are therefore analogous to native quiescent 
Schwann cells awaiting nerve regrowth after injury. We have found that 
they do indeed proliferate in response to an nonal stimulus. 
The chemical nature of the nole m mal mitogen has been somewhat 
enigmatic, although certain properties of the alole mma mitogen have been 
confirmed by all investigators. The mitogen is very sensitive to the action 
of trypsin (Salzer 1 980, .  DeVries 1 983b, Ratner 1 98 4 ). We found that 
trypsin treatment of noiemma (O .OS\ for 30 minutes) abolished its 
mitogenic activity. Heat treatments and repeated freeze-thaw cycles 
reduced the potency of the alolem mal mitogen, b ut these treatments did 
not abolish the activity. This conflicts with the results of elperiments 
using other sources of the neuronal mitogen. Membranes derived from 
either DRG neurites or cultured PC l 2  pheochromocytoma cells are 
mitogenic for Schwann cells b ut their mitogenic activity is more sensitive 
to either heat treatments or freezing and thawing (Ratner 1 984,  Salzer 
1 980c) 
Incubation of the aIolem m al mitogen at 370C for 24  bours did not 
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diminish its activity, whereas the neurite mitogen lost over 80\ of its 
activity under the same conditions. In addition, the neurite mitogen was 
inactivated by freezing and thawing, whereas the potency of the 
axole m mal mitogen was reduced only 3 3 \  after 3 freeze-thaw cycles 
(Salzer , 1 980c). 
One may speculate that either the molecular nature of the mitogen is 
different in the various sources or that the axolem mal mitogen is in a more 
protected environment. The axolem mal mitogen had previously been 
invested with a myelin sheath which could impart some protection not 
shared by the unensheathed neurites or PC 1 2  ceJJs. 
In addition to heat and trypsin sensitivity, the axolemmal mitgen is 
sensitive to sonication and homogenization (De Vries 1 983b,  Pleasure 1 9 8 3 ). 
Together, these data suggest that the mitogen is a protein or is dependent 
on a native protein for its expression. 
Salzer has de monstrated that mitogenic activity is dependent on direct 
contact between axole mma and Schwann ceJJs (Salzer, I 980c). When a 6 m m  
thick permeable coJJagen diaphragm was interposed between growing 
neurites and Schwann celis, no proliferation was observed. We have noted 
that axolem mal membranes appear to adhere to Schwann ceJJs undergoing 
proloiiferation m uch more than do liver me mbranes, and that after trypsin 
treatment of axolem mal membranes, the observed adhesion is m uch 
decreased. This implies that a molecule on the axolem mal surface interacts 
with a receptor molecule on the Schwann ceJJ to promote proliferation. 
We suggest that a glycoprotein molecule could account for the 
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observed properties of the alole m mal mitogen. Glycoproteins have been 
implicated in cell regognition, adhesion, and control of differentiation 
(Stanley, 1 98 1 ;  K.nudsen, 1 9 8  I ;  and Cates, 1 98 4 ). In work with myoblasts, 
Cates found a mutant which lacked a specific 46 ,000 dalton glycoprotein. 
This mutant was unable to undergo either biochemical or morphological 
differentiation or to form myotubules in culture. These myoblasts also had 
reduced binding of the lectin, concanavalin A, which binds mannose rich 
glycoproteins. The authors concluded that the 46,000 dalton 
protein-carbohydrate complel missing in the myoblast mutants was crucial 
for the molecular events leading to differentiation.(Cates, 1 984 )  We have 
found that highly purified endoglycosidase-D, which cleaves mannose rich 
glycoproteins, abolished the mitogenic activity of aIolemmal membranes. 
Thus it is possible that the mitogenic signal for Schwann cells consists, at 
least in part, of an intact glycoprotein. 
The glycoprotein, fibronectin, can act as a mitogen for Schwann cells 
in vitro (A.  Baron-van Evercooren, 1 98 2 )  and, fibronectin has been 
implicated in the development and migration of neural crest cells in two 
recent studies (Duband, 1 982  and Thiery, 1 98 2 ) . Furthermore, cholera 
tOlin, which stimulates Schwann cell proliferation in vitro is known to 
interact with a ganglioside receptor, accenting the importance of 
carbohydrate moities in cell-cell communcation. DeVries et al found, 
however, that preparations of miled brain gangliosides were not mitogenic 
for Schwann cells (DeVries, 1 98 3 )  W e  conclude that there i s  precedence 
for glycoproteins acting as cells transducers and that our data are 
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consistent with the alole m mal mitogen being a glycoprotein. 
Future work will atte mpt to elucidate the nature of the aIole m mal 
mitogen using other endo-glycosidases and characterizing the degradation' 
products of endoglycosidase digestion. In addition, specific plant lectins 
could be used to block the mitogenic signal. This would help identify the 
nature of the active carbohydrate chain(s )  involved, if the mitogen is a 
glycoprotein. 
In addition, efforts to solubilize the aIolem mal mitogen will continue. 
Initial solubilization elperiments have yielded inconsistent results in 
agreement with the work of Cassel. (Cassel, 1 98 3 )  Although 50\ of the 
mitogenic activity was recoverable in octylglucoside solubilized material, 
the activity was so labile that purification could not be atte mpted. We tried 
to reconstitute the mitogenic activity into brain lipid vesicles in order to 
provide a stable lipid environment. This approach had been successful in 
the purification of the acetylcholine receptor (Paraschos, 1 982) ,  but initial 
atte mpts at reconstitution of the mitogenic signal have been unsuccessful. 
Myelin as a Schwann Cell Mitogen 
The aIolemmal mitogen accounts for Schwann cell proliferation 
during development and regeneration, but a mitogen present in myelin 
probably causes Schwann cell proliferation and dedifferentiation during 
Wallerian degeneration. Our results suggest that such a mitogen is present 
in the myelin enriched fraction of rat CNS and is different from the 
aIolem mal mitogen. This concept is supported by in vivo and in vitro 
8 1  
observations of Wallerian degeneration which suggest that myelin itself 
promotes Schwann cell stimulation.(Holtzman, 1 965  and Salzer, 1 980a) 
Our results confirm that myelin possesses mitogenic activity and point 
to differences between the axole m mal signal and the myelin associated 
mitogenic activity. We found that the myelin enriched fraction from rat 
CNS stimulates Schwann cell proliferation as efficiently as the axolemma 
enriched fraction. Activity was greatest in  a fraction containing primarily 
compacted myelin. This suggests that activity resides in myelin and not in 
Schwann cell plasma membranes, and is consistent with the finding that 
only myelinated axons stimulate Schwann cell proliferation in intact nerves 
undergoing Wallerian degeneration.(Salzer, 1 980a and Joseph, 1 950)  
Though the axolem mal mitogen appears to be a protein on the basis of 
its susceptibility to repeated freeze thaw cycles, heat denaturation and 
trypsin digestion, the myelin associated activity does not appear to be a 
native protein. It is resistant to trypsin digestion and freezing and thawing, 
and its activity is actually enhanced by a prolonged (2 hour) incubation at 
1 0 0°e. This data argues strongly against the myelin associated activity 
being due to axole mmal contamination since the activity is present under 
conditions known to abolish axole m mal mitogenic activity. In addition, 
myelin stimulated Schwann cells appear to have increased vacuolization 
which probably represents Iysozomal activity. This again is consistent 
with the finding that Schwann cell proliferation and phagocytic activity are 
linked during Waller ian degeneration.(Hall, 1 976 and Holtzman, 1 96 5 )  
The che mical nature of the myelin associated mitogen is unclear. As 
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noted above, it does not seem to be a native protein. Therefore, it may be 
a protein fragment or a product of protein degradation. Another growth 
factor, fibroblast growth factor, has been proposed to be a breakdown 
fragment of myelin basic protein ( MBP), a major protein constituent of CNS 
myelin. The intact MBP molecule is not mitogenic, and the author proposes 
that proteolysis of the protein could give rise to an activity quiescent in the 
intact molecule (Westall, 1 976) .  A similar mechanism could account for the 
activation of the myelin associated Schwann cell mitogen. Specifically, the 
mitogen may be activated during lysozymal processing of degenerating 
myelin. Alternately, the myelin associated mitogenic activity could be 
attrib uted to a lipid molecule. 
In recent work, inositol phospholipids have been found to be 
important in signal transduction at the cellular level. Phosphatidyl inositol 
(PI )  comprises approximately 3 \  of the total lipids in myelin (DeVries, 
1 980). It has been suggested that the PI in myelin is in a metabolically 
stable pool (Nishizuka, 1 984). But it is possible that during the degradation 
of myelin, triphosphorylated inositol would be released and thereby 
activate a cascade of metabolic activity resulting in mitosis. Such a cascade 
has been studied in platelets where PI is a second messenger in the process 
of the release of platelet granules. The metabolism of PI leads to an 
increase in intercellular calcium, diacylglycerol, and subsequent activation 
of protein kinase C (Nishizuka, 1 984).  Since these consequences of PI 
metabolism are measurable, validation of the involvement of 
phosphoinisotol in myelin induced Schwann cell proliferation should be 
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feasible. 
Experiments to determine the Ca++ concentration in Schwann cells 
during stimulation are now underway in our laboratory. Moreover, in 
other cellular activities such as glycogenolysis in the liver both PI and 
cAMP act via different mechanisms to produce the same outcome. 
(Kaibuchi, 1 982 )  Since we know that Schwann cell proliferation is called 
for in at least two different physiologic circumstances, and that cAMP can 
induce Schwann cell proliferation, PI mediation may turn out to provide a 
mechanism whereby a separate positive control over proliferation is 
exerted. 
Axolemma Enriched Fraction From MS Actively StimUlates 
Schwann Cell Proliferation 
We found that axolemma prepared from MS Plaque stimulates 
Schwann cell proliferation significantly more than does axolemma from 
normal human brain. This would seem far removed from a physiological 
response, since Schwann cells normally reside in the PNS and MS plaque is 
formed in the CNS. However, remyelination in MS with peripheral type 
myelin has been observed in the spinal cord ( I toyama, 1 983 ;  Chatak , 1 973;  
and Prineas, 1 978) .  Staining with the peripheral myelin protein Po 
confirmed that morphologically idenifiab1e PNS myelin located in the CNS 
contained PNS protein constituents ( Itoyama, 1 98 3 ). 
It was suggested that the Schwann cells which produced the myelin 
had migrated into the CNS from dorsal and ventral spinal roots (through a 
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damaged glia limitans). However, other studies of normal CNS have 
confirmed that Schwann cells reside in CNS in the absence of demoristrable 
pathology (Raine, 1 976). In fact, Adelman and Aronson reported that 40\ 
of otherwise normal spinal cords from a large series of atopsies contained 
Schwann cells (Adelman, 1 972). Thus, Schwann cells could be in a position 
to respond to a mitogen present in MS plaque. 
The question then arises as to why Schwann cells should respond and 
create myelin when the CNS counterpart of Schwann cells, the 
oligodendrocyte, seems a more likely candidate. In our studies with 
oligodendrocytes, we were unable to stimulate proliferation using any 
known mitogen, including the aIolem mal preparation from human CNS. 
Thus far, other investigators have also failed to identify mitogenic factors 
for oligodendrocytes (Pruss, 1 982). 
Therefore, the oligodendrocyte may be unable to dedifferentiate and 
respond to the normal developmental axolemmal mitogen even if it is 
exposed during demyelination. Schwann cells then are reacting in an 
attempt at remyelination. This, in turn, suggests that the oligodendrocyte 
is the dysfunctional cell in MS since the axonal membranes can still induce 
Schwann cell proliferation and support myelination. 
Summary 
We have prepared a purified population of Schwann celis from 
neonatal rat sciatic nerves. Our method employs mechanical and 
proteolytic cell dissociation, followed by antimotic treatment and then 
85 
anti-thy 1 . 1  complement mediated lysis of fibroblasts. The unambiguous 
identification of Schwann cells and fibroblasts was made possible using 
immunofluorescent antibodies to CNPase and thy 1 . 1  respectively. 
We developed a rapid and reproducible 3H-thymidine uptake assay of 
Schwann cell proliferation and correlated the results of this assay with the 
more tedious autoradiographic method previously e mployed. 
Using this assay of Schwann cell proliferation, we have examined the 
properties of the Schwann cell mitogen derived from an axole m ma 
enriched membrane fraction and have shown that this activity is sensitive 
to heat, proteolytic digestion and endoglycosidase treatments. We have 
suggested that a native glycoprotein is required for the expression of the 
axolem mal mitogen. In addition, solubilization experiments have shown 
that approximately 50\ of the mitogenic activity can be recovered in OG 
solubilized material, b ut that this activiy is extremely labile. 
When the distribution of mitogenic activity across a gradient of brain 
membrane fractions was examined, a second activity was discovered. This 
activity was associated with a membrane fraction rich in compact myelin. 
The myelin associated mitogenic activity differed from the axolem mal 
mitogen. It  was not sensitive to heat treatments, to repeated freeze-thaw 
cylces or to trypsin digestion. 
In  the future, we will further characterize the axolemmal mitogen 
through the use of other endoglycosidases and the identification of sugars 
released by endoglycosidase digestion. We will also proceed with efforts to 
solubilize the axolemmal mitogen and to incorporate the mitogen into lipid 
86 
vesicles in order to preserve its stability. 
Differences between the axolem mal and the myelin associated 
mitogenic activities will continue to be examined. We have noted that 
there is increased Schwann cell vacuolization concomitant with myelin 
induced proliferation. In vivo observations of Wallerian degeneration have 
linked phagocytic and lysosomal Schwann cell activity with proliferation. 
If this is true, then by inhibiting lysosomal activity with mitomycin C, 
NH4C1, or chloroquine, we could specifically inhibit the myelin associated 
mitogenic activity. 
In both in vivo and in vitro observations of Wallerian degeneration, 
the onset of Schwann cell proliferation has occured about four days after 
nerve damage, whereas 8.lolemmal induced proliferation occurs almost 
immediately. Therefore, a careful examination of the time course and 
kinetics of myelin versus axolem m al induced Schwann cell proliferation 
may yield other characteristic differences. 
Finally, we have postulated that the myelin associated mitogen could 
be either a breakdown product of a protein or a lipid molecule released 
during lysosomal processing of myelin. Efforts to characterize and purify 
the myelin associated mitogen are now underway in our laboratory. 
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